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Abstract
Rift Valley fever virus (RVFV) is a mosquito-borne RNA virus that infects humans and
livestock in sub-Saharan Africa and the Arabian peninsula, causing disease ranging from a
mild flu-like illness to liver damage, blindness, hemorrhagic fever, death, and, especially in
livestock animals, high rates of abortive pregnancies. There is no approved vaccine for RVFV,
and as a disease with a high rate of spread that causes severe illness, it is listed as a Category
A pathogen by the USA CDC. A better understanding of RVFV’s molecular virology will be
instrumental to combating RVFV as climate change causes its mosquito host range to expand.
RVFV infection causes global changes to host transcriptional activities, including host
alternative splicing. Untangling these changes in transcription and alternative splicing will
be key to a detailed understanding of viral infection and host responses to viral infection.
Host cellular immunity, which is activated as soon as a viral incursion is detected, is
multifaceted and complex, and many members of the innate immune response also encode
alternatively spliced mRNA isoforms to regulate their activity. In this dissertation, RVFV’s
wide-ranging effects on host transcription and splicing programs is described, and focus is
placed on one particular alternative splicing event in the mRNA for host innate immune
protein RIOK3. Chapter 1 reviews relevant aspects of cellular innate immunity and
alternative splicing of innate immune genes, especially during RNA virus infection, and
emphasizes recent evidence for RNA virus interference of host splicing mechanisms. Chapter
2 highlights our RNAseq work on RVFV-infected cells that shows the widespread changes in
host transcription and splicing during infection, including in RIOK3. In Chapter 3, RIOK3’s
antiviral role in the innate immune response to RVFV infection is demonstrated along with
the observation that expression of the alternatively spliced isoform, RIOK3 X2, correlates
with a diminished innate immune response, which indicates that this alternative splicing
observed in RVFV infection may be important for regulation of innate immunity. Chapter 4
describes studies to more deeply characterize RIOK3’s alternatively spliced isoforms, and
elucidates the importance of host splicing factor TRA2-b for the constitutive splicing of
RIOK3. Of particular interest, we observed that in RVFV-infected cells TRA2-b mRNA is
mostly alternatively spliced to diminish stability and translation, while conversely, TRA2-b
overexpression and concomitant enhanced expression of constitutively spliced RIOK3
mRNA significantly limits RVFV replication. These data show that RVFV infection benefits
from decreased RIOK3 via alternative splicing, and that RIOK3 is an essential member of the
antiviral response. This work also contributes to an emerging story that mRNA splicing is
vitally important for regulation of the innate immune response against viral infection.
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Chapter 1: An introduction to innate immune activation via RIGI signaling and RNA virus-induced alternative splicing of innate
immune members
Overview
In this dissertation, I discuss my work on determining the role of host innate immune protein
RIOK3 during innate immune stimulation by Rift Valley fever virus, a mosquito-borne,
negative sense, single-stranded RNA virus that causes severe disease in humans and
livestock. The purpose of this introductory section is to explain some of the context in the
field to better set up the later chapters. First, I give an overview of innate immunity and the
role of alternative splicing regulation of the innate immune system, specifically during RIG-I
activation. Then, I discuss other examples of some of the specific methods and techniques
that I used to better understand the complex relationship between pathogen and host,
especially RNAseq, used in Chapter 2. Later, I discuss specific examples of other viruses that
cause mis-splicing of host transcripts, much like RVFV does to RIOK3 in Chapter 3. Lastly, I
discuss key mechanisms through which genes are alternatively spliced and the relevant
methods for determining the splicing factors important for a particular splice event, similar
to Chapter 4.

Introduction to innate immunity
The cellular response to viral infection is complex, mobilizing one or several parallel innate
immune pathways at once to aid in cell survival and rejection of the viral invader. The first
steps of innate immune activation occur in every cell, where pattern recognition receptors
1

(PRRs) bind and recognize molecules associated with pathogens, like viral RNA. This triggers
a signal cascade that results in expression of type-I interferons (IFNs), including interferon
beta (IFNB), and other cytokines that warn neighboring cells and activate adaptive immunity
(reviewed in Rehwinkel and Gack, 2020). The most important PRR to discuss for this
dissertation is RIG-I, which senses short double-stranded RNAs in the cytoplasm (including
that of RVFV) (Yoneyama et al., 2004; Ermler et al., 2013). The IFNs activated via RIG-I
signaling are translated and released from the cell, where they act as key signaling molecules,
binding in endocrine or autocrine fashion to IFN receptors and trigger inflammation through
the JAK-STAT pathway.

Innate immunity is tightly regulated to prevent overstimulation and potential for localized
or systemic damage due to excessive reaction to the pathogen. Chronically overactive innate
immunity can cause or exacerbate autoimmune disease and other interferonopathies
(diseases caused by dysregulated interferon signaling) (Rodero and Crow, 2016; Saferding
and Blüml, 2020). Shortly after activation, regulatory mechanisms are rapidly initiated to
mitigate the signaling cascade. Innate immune regulation is possible at multiple levels,
including through transcriptional control, posttranscriptional modifications, and protein
inhibition. Recent reports have demonstrated that posttranscriptional modifications of
mRNA like N6-methylation of adenosine residues (Rubio et al., 2018; Winkler et al., 2019)
and alternative splicing of mRNA can be important regulatory mechanisms. Alternative
splicing is used by the host cell to control innate immunity at the gene expression level by
changing the major expressed isoform to an inactive or negative competitor (Gack et al.,
2008), expressing a more-active version of the protein (Lad et al., 2008), for constitutive
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expression of a particular innate immunity protein in different tissues (Li et al., 2011a), or to
degrade transcripts via nonsense-mediated decay (Frankiw et al., 2020).

The alternative splicing of innate immune gene mRNA, in response to or because of viral
infection, is of emerging importance in understanding how cells fight off an infection.
Untangling the complex splicing networks that govern innate immune activation in different
cells is an ongoing exploration that will yield insight into both viral infection and host
processes.

Innate immune regulation
Regulation and eventual deactivation of innate immunity is necessary to prevent excessive
immune signaling and acute or chronic disease. A common immediate consequences of
excessive innate immune activation is hyperinflammation, which can cause acute illness in
infected individuals due to an overactivation of genes that are normally used to fight
infection. Often, multiple mechanisms exist to inhibit a particular member of the innate
immune pathway from causing hyperinflammation. For example, the double-stranded RNA
(dsRNA) sensor RIG-I, one of the cell’s first lines of defense against dsRNA virus infection, is
negatively regulated through several mechanisms activated shortly after RNA sensing. A
2017 kinase screen identified death associated protein kinase 1 (DAPK1) as a regulatory
kinase that phosphorylates RIG-I during viral infection, deactivating its capacity to detect
RNA (Willemsen et al., 2017). More recently, it was discovered that RIG-I is regulated
through a sequential deamidation, a mechanism that herpes simplex virus 1 (HSV1) co-opts
to replicate more efficiently (Huang et al., 2021). Another example is caspase 8, a protein
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involved in activation of apoptosis, which halts continued innate immune signaling via RIGI and MDA5 by cleaving RIPK1 (Cuda et al., 2015).

Dysregulation of innate immunity can cause enhanced pathology triggered by viral infection.
For example, SARS-CoV-1 and SARS-CoV-2 tweak innate immune signaling away from
interferon production and towards other proinflammatory cytokines. In SARS-CoV-1
infection, this has the effect of reducing T-cell activation and the adaptive immune response
(which would usually aid in viral protection) and increasing innate immune activation via
cytokines (Cheung et al., 2005; Law et al., 2005; Lu et al., 2011; Channappanavar et al., 2016).
This leads to hyperinflammation and the so-called cytokine storms which cause many of the
life-threatening complications of SARS-CoV-2 infection (de la Rica et al., 2020; Huang et al.,
2020). This dysregulation, in both SARS-CoV1 and SARS-CoV-2, is potentially mediated by
the viral nucleocapsid protein, which inhibits the interaction between RIG-I and TRIM25, an
E3 ubiquitin ligase which adds K63 ubiquitin to RIG-I for downstream signaling (Gack et al.,
2009; Lu et al., 2011; Hu et al., 2017b; Oh and Shin, 2021). Alongside nucleocapsid’s effect at
decreasing IFNB signaling, SARS-CoV envelope protein has been shown to increase
inflammatory cytokine production, leading to a dysregulation and potentially a cytokine
storm without clearing the virus through adaptive immunity (Jimenez-Guardeño et al., 2014;
Nieto-Torres et al., 2014; Nieto-Torres et al., 2015). Hyperinflammation and tissue damage
can also occur via other dysregulation; for example, West Nile virus is hypothesized to cause
encephalitis by increasing apoptosis in central nervous system cells (Samuel et al., 2007).

4

Chronic inflammation can also cause long-term autoimmunity. Initial induction of innate
immunity via RIG-I causes expression of type-I interferons (IFNs), which are powerful
signaling molecules whose regulation is essential. Taft and Bogunovic describe IFN
production as a “Goldilocks zone” where chronic expression of too much IFN causes diseases
termed interferonopathies, including systemic lupus erythematosus (SLE), while too little
IFN leaves an individual susceptible to infection (Taft and Bogunovic, 2018).
Interferonopathies in particular can cause autoinflammatory disease and chronic pain, and
other complications beyond increased inflammation (Rodero and Crow, 2016; Crow and
Stetson, 2021). Interferonopathies can occur due to one of many possible failures in innate
immune signaling. For example, mutations that hypersensitize RIG-I could cause overactive
innate immune signaling even in normal cells (Jang et al., 2015), and a loss of function in
ADAR1 leads to MAVS sensing self-RNA in the cytoplasm (Pestal et al., 2015). In SLE,
overactive innate immunity can also be a trigger for autoimmunity; a gain-of-function
mutation was found in MDA5 in an SLE patient, indicating that systemic diseases can be
caused by dysregulated innate immune sensing (Rutsch et al., 2015; Kato et al., 2017).

Dysregulation of innate immunity has dire consequences for individuals, whether caused by
viruses, mutation, or another trigger. Regulation at multiple levels is vital to strike a balance
between enough inflammation to fight off pathogens but not so much that it causes disease
in the individual.

5

Innate immune genes with alternative splice isoforms during RIG-I activation
Alternative splicing is emerging as an important pathway for innate immune regulation. At
least 90% of mRNA transcripts in the human genome are alternatively spliced (Leff et al.,
1986; Black, 2003; Wang et al., 2008; Manning and Cooper, 2017), which allows for
diversification of the coding capacity of the genome by enabling a single gene to encode
multiple proteins with variable functions in different cell types and under different
physiological conditions (Wang et al., 2008). Several mRNAs coding for innate immune
proteins have been shown to be subject to alternative splicing. In fact, it is observed at every
step of the signaling pathway starting with RIG-I and ending in IRF3.
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Figure 1: A schematic illustration of RIG-I activation, with regulatory alternative splice
isoforms highlighted. Splice variants: RIG-I-SV (Gack et al., 2008), TBK1s (Deng et al., 2008),
miniMAVS (Brubaker et al., 2014), MAVS 1a (Lad et al., 2008), MAVS 1b (Lad et al., 2008), IRF3CL (Li et al., 2011a), IRF3-a (Karpova et al., 2001), and IRF3-b (Karpova et al., 2000); see text
for details.
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One mechanism through which innate immune proteins use alternative splicing to regulate
the signal transduction cascade is through the expression of truncated isoforms that act as
dominant negative inhibitors for the functional full-length protein. Expression of the
truncated isoform is usually upregulated shortly after innate immune activation to slow the
signaling cascade and prevent overstimulation. For example, RIG-I pre-mRNA encodes a
shorter isoform (termed RIG-I-SV) missing its CARD domain, which is required for TRIM25
binding, K-63 ubiquitination and ergo activation of RIG-I signaling. RIG-I-SV is expressed 24
hours after Sendai virus (SeV) infection, and its expression leads to a reduced interferon
response by binding and sequestering dsRNA without activating the signaling cascade. This
could have the added effect of preventing viral proteins from binding to viral dsRNA (Gack
et al., 2008). To our knowledge, this splice variant has not been studied further, and the
splicing factor(s) that control it and conditions that trigger it are unclear and would be worth
studying further.

After sensing dsRNA in the cytoplasm, RIG-I interacts with MAVS (also variously known as
CARDIF, IPS-1, KIAA1271 and VISA), which in turn acts as a scaffold to activate downstream
signaling proteins (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005).
MAVS protein appears as several bands on a western blot, and at least some of these smaller
bands are generated through alternative splicing (Lad et al., 2008). Lad et al., found that the
MAVS gene expresses three splice isoforms via exon skipping, termed MAVS 1a, MAVS 1b,
and MAVS 1c. The authors reported that expression of the protein encoded by MAVS 1a was
8

inhibitory to RIG-I/MAVS signaling and that MAVS 1b activated IFNB expression. Usually,
MAVS activates IFNB signaling and NF-kB signaling, the latter being another innate immune
pathway which regulates separate innate immune signaling cascades from IFNB. The MAVS
1b isoform increased IFNB signaling but not NF-kB, indicating that the full-length protein
may have separate regions for regulation of both pathways. Overall, this research implies
that MAVS may encode splice isoforms with variable activity as a means to differentially
regulate antiviral activation. The authors did not investigate the conditions of expression for
each MAVS splice isoform, so further investigation into the regulation of each isoform may
be important, as each appears to have a specific role.

TBK1, which is downstream of MAVS in the dsRNA sensing signaling cascade, encodes a
truncated isoform known as TBK1s. Typically, TBK1 binds to MAVS and phosphorylates IRF3
in response to immune stimulation (Figure 1). The truncated TBK1s isoform instead binds
RIG-I and inhibits its activity, reducing interferon activation. In SeV-infected cells, TBK1s is
expressed as early as 6 hours post infection and reduces the induction of innate immunity
(Deng et al., 2008). Interestingly, TBK1s specifically reduced signaling via RIG-I through
IRF3, but did not affect NF-kB signaling, another innate immune signaling pathway of which
TBK1 is a member. The researchers were unable to knock down expression of TBK1s
specifically, so targeted disruption of splice enhancer/silencer sites may be necessary to
better understand the role of this truncated splicing product.

IRF3 is phosphorylated by TBK1 upon viral recognition, which causes it to homodimerize or
heterodimerize with IRF7, enter the nucleus, and begin promoting expression of IFNB and
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other interferon-related genes (Yoneyama et al., 1998). Like members in the pathway
preceding it, IRF3 is regulated via truncated alternative splicing isoforms (IRF3-a, IRF3-b,
IRF-CL, among others) which act as dominant negative inhibitors of the pathway (Karpova
et al., 2000; Karpova et al., 2001; Li et al., 2011a; Li et al., 2011b). Interestingly, these
truncated isoforms are apparently expressed constitutively in many cell types, with
expression higher in brain tissue, where overactive innate immunity can cause encephalitis.
Expression has also been observed to be high in cancer cells, where innate immunity is often
deactivated to prevent detection (Karpova et al., 2001; Li et al., 2011b). It was not
investigated whether activation of RIG-I induced more alternative splicing of IRF3 mRNAs in
cells, but it was found that serine-arginine rich (SR) splicing factor SRSF1 and hnRNP A1
were required for splicing the full-length isoform of IRF3 (Guo et al., 2013). If a viral invader
were to interfere with either of these splicing factors, they might have an advantage in the
cell by causing overexpression of an inhibitory isoform of IRF3.

Recently, our group demonstrated that a shorter isoform of atypical protein kinase RIOK3,
encoded by an alternatively spliced mRNA isoform termed RIOK3-X2, is highly expressed in
infected or immune-stimulated cells. The truncated X2 protein is missing most of its putative
catalytic domain and, when expression of the X2 variant is enhanced by treatment of cells
with a splice-switching morpholino oligo, results in lower interferon-beta expression
(Havranek et al., 2021). RIOK3’s exact role in innate immunity remains unclear, as in
different contexts it may be an inducer (Feng et al., 2014; Havranek et al., 2021) or a negative
regulator (Shan et al., 2009; Takashima et al., 2015; Shen et al., 2021) of innate immunity,
depending on the infecting virus, interactions with different members pathogen recognition
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receptor family, cell type, etc. However, our results indicate that the RIOK3-X2 isoform is
likely important to its activity and expression, and investigation its role may provide insight
into the contradictory research into RIOK3 thus far.

Alternative splicing is also used by host cells to regulate core members of the innate immune
pathway outside of RIG-I activation, including OAS1 (Frankiw et al., 2020), cGAS (Hancks et
al., 2015), STING (Chen et al., 2014; Rodríguez-García et al., 2018), MyD88 (Lee et al., 2020),
and Toll-like receptor signaling (Wells et al., 2006; O’Connor et al., 2015), among many
others. Investigation of the often large number of genes alternatively spliced during an
infection is a key step to understanding how viruses interfere with the antiviral response.

Transcriptomic approaches to investigate virus-mediated alternative splicing
changes
Viral infection induces global changes to gene expression, including massive alterations to
the cellular splicing program. Transcriptomics data has been generated by RNAseq to
reinforce this assertion in many viral systems, including data from RNA viruses, DNA viruses,
and retroviruses. RNAseq’s cost has decreased significantly while its effectiveness has
increased, making it an excellent and broad method for determining large-scale splicing
changes in host cells.

We used RNAseq to investigate the transcriptional landscape during Rift Valley fever virus
(RVFV) infection, and we identified 3125 differentially regulated and 1499 differentially
spliced genes in infected cells compared to mock infected cells (Havranek et al., 2019). We
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observed extensive upregulation of antiviral genes, which is expected despite viral inhibition
of innate immune activation; this was largely in agreement with another transcriptomics
study on RVFV-infected cells (Pinkham et al., 2017). With regards to alternative splicing, we
used Gene Ontology (GO) to identify trends of alternatively spliced genes (Ashburner et al.,
2000). Alternatively spliced genes were enriched in GO terms related to RNA processing,
including splicing, indicating that genes involved in splicing are also alternatively spliced
during infection. In particular, we found three SR splicing factors that were alternatively
spliced such that the major isoform was a nonfunctional isoform: TRA2-b, TRA2-a, and
SRSF11. Depletion any of these three, but particularly TRA2-b and SRSF11, could influence
splicing of other genes. Identification of genes under the control of these three splicing
factors may prove useful to understanding RVFV infection and its effect on host cells. Indeed,
these transcriptomics data allowed us to identify TRA2-b as a splicing regulator for RIOK3, a
protein involved in innate immunity (White et al., 2021).

While RNAseq is an excellent tool to study global and widespread changes in mRNA
expression, investigation of splicing via transcriptomics data could lead to different nonmutually exclusive but distinct interpretations for several reasons. First, it is possible that
alternative splicing appearing after infection is caused by the virus to enhance its survival
and replication, or by the cell in defense of the infection.

Therefore, transcriptome

comparisons of infected cells to cells stimulated through nonviral immune agonists, such as
poly(I:C) or 3p-hpRNA may be necessary. Cultured cells may also have expression and
splicing patterns that are dissimilar to cells in vivo. Different cell types might have different
cellular responses to viral infection, and different viral strains may have different effects on
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host splicing and innate immune activation. Additionally, gene expression and splicing can
be variable even within the same cell culture, depending on passage and culturing technique
(Zaitseva et al., 2006), and the most straightforward RNA-seq methods analyze a pool of
collected tissue culture, which may have different levels of infection in each cell. Single-cell
transcriptomics, which is becoming more affordable due to advances in separation and
sequencing techniques, may provide a clearer picture of the splicing and transcriptional
landscape in infected cells (Hu et al., 2016; Adil et al., 2021). Because of low read counts and
high noise data implicit in single-cell transcriptomics data, new bioinformatics methods
must be developed to focus on comparing alternative splicing in infected cells (Huang and
Sanguinetti, 2017; Song et al., 2017; Vallejos et al., 2017). Also, it is possible that different
viral strains may have a different effect on host splicing, even in the same cell type; for
example, a more pathogenic strain may encode a functionally active splice disruptor, while a
nonpathogenic lab strain may be deficient for that virulence factor.

Regardless of limitations, transcriptomics is a powerful tool that, with sequencing rapidly
becoming more affordable, has the potential to deeply probe virus-caused splicing changes.
Establishing an inventory of genes that are subject to alternative splicing during infection is
the first critical step toward understanding the underlying virus-host interactions impacted
by these changes.

Mechanisms through which RNA viruses affect alternative splicing
Pathogenic viruses of every type, from RNA viruses to DNA viruses, cause alternative splicing
of host genes. Of particular interest is the RNA viruses that replicate in the cytoplasm;
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because these viruses do not have access to the spliceosome and therefore do not
alternatively splice their own genes, their disruption of splicing is directed squarely at
dysregulation of host genes. Table 1 highlights the known cytoplasm-replicating RNA viral
proteins that affect alternative splicing in host cells, the proteins they target, and the host
pre-mRNAs that are alternatively spliced because of viral disruption.

Table 1: A summary of splicing disruptions caused by cytoplasm-replicating RNA viruses.
Virus

and

viral

component
involved
Virus

(where

Host

genes

known)

Type of effect

Host gene affected

alternatively spliced

Reference

NSP16

Spliceosome

snRNA U1/U2

ISG15

(Banerjee et

Coronaviridae
SARS-CoV-2

disruption

and

observed

others
through

al., 2020)

transcriptomics
Picornaviridae
Poliovirus

2A protease

Splicing factor

HuR, TIA1, TIAR

Fas

mislocalization
Unknown

Splicing factor

(Álvarez et
al., 2013)

PTB, SRSF3

Unknown

mislocalization

(Florez
al.,

et

2005;

Bedard

et

al., 2007)
Cocksackievirus

Unknown

Splicing factor
mislocalization

PSF

Unknown

(Dave et al.,
2017)

14

Enterovirus

3DPOL

Spliceosome

Prp8

NCL

(Liu et al.,

disruption

2014)

Togaviridae
Sindbis virus

3’UTR

of

transcripts

viral

Splicing factor

HuR

ELAVL1

mislocalization

(HuR),

CALCA, PTBP2, DST

(Garneau et
al.,

2008;

Sokoloski et
al.,

2010;

Dickson
al.,

et

2012;

Barnhart et
al., 2013)
Unknown

Splicing factor

hnRNP A1

Unknown

(Gui et al.,

mislocalization

2010)

Flaviviridae
Dengue virus

NS5

Spliceosome

CD2BP2,

DDX23,

disruption

EFTUD2, RBM10

ZNF35, Casp8, RIG-I,

(De Maio et

SAT1

al.,

and

observed

Zika virus

sfRNA

Spliceosome

SF3B1

others
through

2016;

Pozzi et al.,

transcriptomics

2020)

SRSF7

(Hu et al.,

disruption

2017a;
Bonenfant
et al., 2020)

Arenaviridae
Junín virus

Unknown

Splicing factor
mislocalization

hnRNP A1

Unknown

(Maeto
al., 2011)

Phenuiviridae
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et

Rift Valley fever

Nucleocapsid

Unknown

Unknown

RIOK3, TRA2-b

virus

(Hayashi et
al.,

2021),

unpublished
data
Rhabdoviridae
Vesicular

M1, M2, M3

stomatitis virus

Splicing factor

hnRNPs,

mislocalization

hnRNP K

especially

TIA1

(Pettit
Kneller
al.,

et

2009;

Dinh et al.,
2013;
Redondo et
al., 2015)
Reoviridae
Orthoreovirus

µ2

(strain T1L)

Splicing factor

SRSF2

binding

SRSF3, SRSF6, SRSF7,

(Rivera-

SRSF11

Serrano

et

al., 2017)
Rotavirus

NSP2, NSP5

Splicing factor

hnRNPs

Unknown

(Dhillon et

mislocalization
NSP3

Spliceosomal
disruption(?)

al., 2018)
eIF4G

XBP1
splicing)

(nuclear

(Duarte
al., 2018)

Documented examples of viral disruption of host splicing fall into two broad categories:
splicing factor mislocalization and spliceosomal disruption. During splicing factor
mislocalization, one or more viral factors causes splicing factors to be translocated out of the
nucleus, where they aid in splicing of pre-mRNA, into the cytoplasm, where they sometimes
aid in viral replication. This mislocalization can cause mis-splicing of host mRNA; for
example, poliovirus 2A protease causes translocation of splicing factor and RNA stabilization
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et

protein HuR into the cytoplasm, where it binds and stabilizes viral RNAs (Álvarez et al.,
2013). This causes host gene Fas to become alternatively spliced in favor of a shorter isoform
that prevents apoptosis, benefiting the virus (Izquierdo et al., 2005). This is a remarkable
viral evolutionary strategy to evade the host antiviral response, and has been shown in
several viruses across orders. Many splicing factors also act as RNA stabilizing elements
(Gupta et al., 2013) and aid in viral replication (Gui et al., 2010), so it is unknown whether
all splicing factor mislocalization events directly target splicing factors that regulate
expression of host antiviral genes or whether mis-splicing of host antiviral genes is simply
“collateral damage” during infection. Regardless, viral commandeering of host splicing
factors has been shown to be a powerful strategy that aids in viral replication.

The other broad category of viral intrusion into splicing is through direct disruption of the
spliceosome. Generally, viral nonstructural proteins enter the nucleus and preferentially
bind host spliceosomal proteins or mRNA. For example, SARS-CoV-2 NSP16 preferentially
binds snRNAs U1 and U2, which are necessary for splice site selection (Banerjee et al., 2020).
Another example is Dengue virus NS5, the viral RNA-dependent RNA polymerase, which
enters the nucleus and binds and inhibits spliceosomal proteins (De Maio et al., 2016; Pozzi
et al., 2020). In either case, this targeted disruption of general spliceosomal factors causes
mis-splicing in many host genes, including antiviral genes ISG15 (in SARS-CoV-2 infection)
and RIG-I (in Dengue virus infection). Because these host factors are necessary for normal
expression of many disparate host genes, it appears that this strategy is a viral mechanism
to interfere with RNA processing in general, as opposed to a targeted attack on specific
antiviral genes. A smaller sub-category should also be highlighted for orthoreoviruses, which
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express a nonstructural protein µ2 that binds to and apparently inhibits the function of host
splicing factor SRSF2, causing large splicing changes in host cells (Rivera-Serrano et al.,
2017). Unlike “spliceosomal disruption,” this type of disruption causes only pre-mRNA
targeted by SRSF2 to be mis-spliced; however, since splicing factors often regulate the
splicing of other splicing factors, inhibition of one splicing factor could have far-reaching
effects on a host cell.

Though it is a nuclear-replicating virus that co-opts host splicing factors to splice its own
genes, it is worth mentioning influenza A virus (IAV) because it interferes with host splicing
via both splicing factor mislocalization and splicing disruption. IAV mislocalizes hnRNP K,
which is required for splicing of its own genes, to the viral replication centers in nuclear
speckles; in doing so, it causes hnRNP K-regulated pre-mRNA to be mis-spliced, which is also
beneficial to the virus (Thompson et al., 2020). With regard to spliceosome disruption, IAV
NS1 has also been shown to directly bind to snRNA U6 and to intronic sequences. Through
these interactions, NS1 can inhibit and alter splicing of host mRNA (Fortes et al., 1994; Qiu
et al., 1995; Wang and Krug, 1998; Zhang et al., 2018a). Additionally, IAV NS1 protein
appears to target specific host factors for alternative splicing. NS1 causes alternative splicing
of host tumor suppressor factor p53 to enhance production of the p53b isoform, which
promotes genes that are beneficial to the virus (Dubois et al., 2019) in a mechanism that may
be related to p53b’s role in promoting senescence rather than apoptosis (Chen et al., 2021).

Regardless of whether a virus requires host splicing factors to replicate, many are able to
interfere with host splicing. The careful investigation of which viral factors interact with
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specific splicing factors and spliceosome components will be an important field of study to
understand how they subvert the antiviral response.

Methods for probing splicing factors responsible for mRNA splicing
While it is a complex made up of many proteins and RNAs that carry out multiple catalytic
steps, the spliceosome uses a relatively minimal signal to catalytically activate splicing: a 5’
splice donor site, a 3’ splice acceptor site, and a branch point (Zhang, 1998; Thanaraj and
Clark, 2001). Splice sites from different genes share some sequence similarity, such as the 5’
splice site having a consensus sequence of CAG|GUAAGUAU (with “|” denoting the splice
junction) (Roca et al., 2012) and branch points occurring at motifs consisting of YNYYRAY (Y
= U or C, N = any nucleotide, R = G or A) (Vigevani et al., 2017). However, the spliceosome
must relies on splicing factors to determine which splice site is selected at different times.
Splicing factors are RNA binding proteins that can bind exons or introns and may enhance
or silence splice site usage (or both, depending on the transcript) (Long and Caceres, 2008).
Splicing factors typically have site specificity towards a particular motif, clusters of which
are often evolutionarily conserved (Goren et al., 2006; Ule et al., 2006). Splicing factors form
complex regulatory networks by regulating other splicing factor mRNA (and sometimes their
own), making it difficult to study the effect of one particular splicing factor (Leclair et al.,
2020). Splicing factors can also be regulated by cycles of phosphorylation and
dephosphorylation, adding another layer of complexity to these proteins (Mermoud et al.,
1994).
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RNAseq-based approaches are useful for determining the often extensive targets of
particular splicing factors. RNAseq can be used to investigate RNA that is bound by particular
splicing factors through cross-linking immunoprecipitation (CLIP) followed by RNAseq, or
can be used following an siRNA knockdown to investigate alternative splicing in the absence
of a particular splicing factor. CLIP can be a powerful tool to identify both genes targeted by
a particular splicing factor, and also to identify consensus sequences/motifs that an splicing
factor might target. For example, Best, et al., identified 53 genes under the control of SR
splicing factors TRA2-b and TRA2-a (Best et al., 2014). Through this study, they were able
to identify TRA2-b’s role in regulating the DNA damage response and also recapitulate the
biochemically-determined consensus motif of repeated clusters of AGAA (Cléry et al., 2011;
Tsuda et al., 2011). Similar CLIP-based sequencing studies have been carried out for splicing
factors U2AF2 and LIN28 (Wilbert et al., 2012; Sutandy et al., 2018), helping to identify some
of the complex networks defined by splicing factors.

Knockdown of a splicing factor followed by RNAseq can aid in untangling the complex
regulatory networks governed by splicing factors. One knockdown study on the serinearginine (SR) splicing factors has provided insight into the roles that these networks play in
cancer tissue (Leclair et al., 2020). The authors found that disruption of any one SR splicing
factor was enough to disturb the expression of other SR splicing factors, and find that
targeted disruption of TRA2-b can cause a decrease in viability in breast cancer cells. In a
similar study, the authors knocked down SR splicing factors and hnRNPs, then infected cells
with Salmonella, and observed similarly regulated networks of splicing factors (Wagner et
al., 2021). Interestingly, overexpression of hnRNP K and U was restrictive to vesicular
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stomatitis virus infection, suggesting a role for these splicing factors in innate immune
activation. While large-scale sequencing techniques have been used to identify trends in
splicing factor binding, confirmation and a better understanding of a particular splice event
requires more specific molecular-level assays.

Splicing minigenes are a plasmid-based method to test splicing An intron-exon containing
region of interest is cloned into a common vector and processing of ‘mRNA’ expressed from
the minigene is assessed via RT-PCR or RT-qPCR (reviewed in Cooper, 2005). The advantage
of minigenes is that, by virtue of the fact that they are plasmid-based, they are relatively easy
to mutate through site-directed mutagenesis or cloning of in vitro-generated DNA sequences.
Minigenes were initially used to determine the sequences important for exon splicing in the
TNNT2 and FN1 genes (Mardon et al., 1987; Cooper and Ordahl, 1989), and were later used
to show binding of SR splicing factors to TNNT2 exon 5 and YB-1 binding to CD44 exon 4
(Ramchatesingh et al., 1995; Stickeler et al., 2001). Minigenes are also useful because they
can be co-transfected with splicing factor knockdown siRNA or splicing factor
overexpression vectors, which allows more fine-tuned control of potentially important
binding sites. The limitation of minigenes is that they do not always exactly recapitulate the
splicing of the endogenously-generated mRNA. In our own work, where we identified TRA2b binding to and enhancing full-length usage of RIOK3 exon 8, the RIOK3 minigene-derived
mRNA had much greater abundance of the truncated isoform than endogenously-derived
mRNA, though the overall trend was the same for both (White et al., 2021).
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Another useful tool to identify splicing factor binding sites in endogenously-expressed
mRNA is with transfected splice-switching oligonucleotides (SSOs) to occlude putative RNAprotein interaction binding regions (reviewed in Havens and Hastings, 2016). One of the first
reports of an SSO causing alternative splicing was in the Duchenne’s muscular dystrophyrelated gene DMD, where the authors demonstrated that the characteristic mis-splicing of
the DMD gene could be corrected via treatment with an SSO (Takeshima et al., 1995). Animal
studies have shown that SSOs could be safe and effective treatments for Duchenne’s
muscular dystrophy (Sazani et al., 2010; Sazani et al., 2011). SSOs were used extensively by
Leclair et al., in a study of splicing factor TRA2-b; after a large-scale knockdown experiment
targeting several SR splicing factors, they used SSOs to confirm the regulatory regions in
target mRNA, and then studied the effects of SSOs on splicing in breast cancer cell lines,
reducing cancer cell viability (Leclair et al., 2020). SSOs are limited in their effectiveness by
the challenge of cell/tissue and dosage-appropriate delivery, especially in in vivo
experiments or potential therapeutic regimens (Godfrey et al., 2017). However, SSOs are
quite useful as a tool to directly manipulate splicing patterns of cells in culture, and these
studies could lead to the use of SSOs as powerful tools in human health.

Despite multiple methods for measuring the target of a splicing factor, it remains tedious to
determine the splicing factor(s) responsible for exact splice events. Nevertheless,
understanding the proteins at play in important splicing events will be helpful to understand
more about the cell’s response to viral infection.
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A roadmap to the research presented in this dissertation
In the rest of this dissertation, I follow a similar structure as this introductory section. I will
discuss transcriptomics of RVFV-infected cells in Chapter 2, where I also describe several
alternative splicing events, among them host innate immune protein RIOK3. In Chapter 3, I
further investigate the interactions between RVFV and RIOK3, showing that alternative
splicing of RIOK3 observed during RVFV infection is detrimental to RIOK3’s role in the cell
to activate IFNB expression. Then, in Chapter 4, I describe that the splicing factor TRA2-b
promotes full-length RIOK3 splicing using several methods highlighted above, especially
minigenes and splice-switching oligos. Lastly, in Chapter 5, I discuss my research in relation
to other work in the field, and lay out future perspectives and experiments that may be
helpful for understanding RIOK3’s unique function in innate immunity.
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Chapter 2: Transcriptome profiling in Rift Valley fever virus
infected cells reveals modified transcriptional and alternative
splicing programs
Katherine E. Havranek, Luke Adam White, Jean-Marc Lanchy, and J. Stephen Lodmell

This chapter is a modified version of our co-authored manuscript published in PLOS One
(Havranek KE, White LA, Lanchy JM, Lodmell JS. Transcriptome profiling in Rift Valley fever
virus infected cells reveals modified transcriptional and alternative splicing programs. PloS
One. 2019;14(5):e0217497. PMCID: PMCPMC6538246). In this version of the manuscript,
several figures and text were removed that were not relevant to this dissertation. Luke White
contributed Figures 4 and 5, the latter of which is new to this version. New text was added
in support of the new data presented.
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Abstract
Rift Valley fever virus (RVFV) is a negative-sense RNA virus belonging to the Phenuiviridae
family that infects both domestic livestock and humans. The NIAID has designated RVFV as
a Category A priority emerging pathogen due to the devastating public health outcomes
associated with epidemic outbreaks. However, there is no licensed treatment or vaccine
approved for human use. Therefore it is of great interest to understand RVFV pathogenesis
in infected hosts in order to facilitate creation of targeted therapies and treatment options.
Here, we provide insight into the host-pathogen interface in human HEK293 cell culture
during RVFV strain MP-12 infection using high-throughput mRNA sequencing technology.
Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of
differentially expressed genes showed robust innate immune and cytokine-mediated
inflammatory pathway activation as well as alterations in pathways associated with fatty
acid metabolism and extracellular matrix receptor signaling. Lastly, we noted dramatic
changes in host alternative splicing patterns in genes associated with mRNA decay and
surveillance, RNA transport, and DNA repair, and analyzed splicing factors that were
differentially expressed and/or alternatively spliced. This study has improved our
understanding of RVFV pathogenesis and has provided novel insight into pathways and
signaling modules important for RVFV diagnostics and therapeutic development.
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Introduction
Rift Valley fever virus (RVFV) is a mosquito-borne zoonotic disease that was originally
discovered in the Kenyan Rift basin in the 1930s (Daubney, 1931). The virus has since spread
throughout Sub-Saharan Africa and has more recently extended its reach outside of the
African continent into the Arabian Peninsula (Madani et al., 2003). More than fifty mosquito
vector species can transmit the virus, including species whose home range spans well into
portions of the Americas, such as Aedes aegypti mosquitos that carry other viruses like Zika,
chikungunya, yellow fever and dengue (Linthicum et al., 2016). RVFV causes severe disease
in both livestock and humans. Epidemics in livestock yield 10-20% mortality in adults and
cause what have been termed ‘abortion storms’ in fetuses and neonates, since mortality rates
can rise as high as 100% (Coetzer and Tustin, 2004). In humans, the virus causes an array of
clinical manifestations ranging from mild flu-like illness to severe complications including
blindness, meningoencephalitis, hemorrhagic fever and death (Ikegami and Makino, 2011);
there is also evidence that humans infected with the virus are more likely to have miscarriage
(Baudin et al., 2016). High rates of human infection coincide with above average periods of
rainfall and flooding, which provide ripe conditions for an overabundance of mosquito
vectors. RVFV has already demonstrated both its potential for spread outside of endemic
regions and its ability to cause devastating public health and economic impacts.
Furthermore, there is no licensed vaccine for human use, although there is ongoing vaccine
testing in livestock (Indran and Ikegami, 2012).

RVFV is a tri-segmented negative-sense single-stranded RNA virus belonging to the
Phlebovirus genus within the Phenuiviridae family (Adams et al., 2017). The viral genome
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consists of three segments designated large (L), medium (M) and small (S), which encode the
viral RNA-dependent RNA polymerase, the viral glycoproteins Gn and Gc and nonstructural
protein NSm, and the viral nucleocapsid protein N and the nonstructural virulence protein,
NSs, respectively. These few viral proteins, in conjunction with host proteins, ensure that the
virus can replicate its genome during a productive infection. Virus-host interaction is
paramount for viral progeny production and therefore it is of great interest to understand
how these interactions shape the cellular landscape during viral infection. The rising trend
of high throughput mRNA sequencing has enabled a profound appreciation for the cellular
transcriptomic overhaul that occurs as a result of disease progression, cancer state, or
environmental condition. However, relatively few mRNA-seq studies to date have
characterized host response to viral infection. The studies that have risen to this challenge
have revealed novel insights into host-pathogen dynamics. A deeper understanding of the
host response to viral infection will contribute to the development of effective treatment
options and targeted therapies. In this study, our objective was to characterize changes in
gene expression that occur during attenuated RVFV strain MP-12 infection, as well as
alterations in host splicing.

Materials and methods
Cell culture and viral infections
HEK293 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) with 10% fetal
bovine serum and 1% penicillin/streptomycin. For experiments using MP-12 RVFV, 80-90%
confluent HEK293 cells were washed with phosphate-buffered saline (PBS) and overlaid
with virus at the specified MOI in DMEM without serum or antibiotics and incubated for one
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hour at 37°C and 5% CO2. After incubation with virus the media was replaced with DMEM
supplemented with 2% fetal bovine serum and the cells were maintained at 37°C and 5%
CO2 until time of harvest. Viral infection was confirmed using immunofluorescence targeting
the viral nucleocapsid protein as well as RT-qPCR amplification of the viral small genome
segment.

RNA Sequencing
Total RNA was extracted from infected and uninfected cells using the PureLink RNA Mini Kit
(Thermo Fisher Scientific) and RNA integrity was verified using TapeStation 2200
Bioanalyzer (Agilent) and agarose gel electrophoresis. High quality RNA samples
representing triplicate infected or mock-infected cells were submitted to Novogene for
commercial RNA-sequencing (Novogene Beijing, China). Poly-A mRNA was selected from
total RNA using oligo-dT bound magnetic beads and strand specific NEBNext Ultra RNA
libraries were synthesized for paired-end 150 bp (PE 150) on an Illumina HiSeq 2000
platform (Illumina Inc.). Base calling was performed using CASAVA and raw data was stored
as FASTQ files. Reads were filtered for quality and aligned to the GRCh-37 (hg19) genome
using TopHat2 to generate BAM files (Kim et al., 2013). DESeq2 R package was used to
identify differentially expressed genes (DEGs) in MP-12 infected cells relative to mock
infected cells (Love et al., 2014). For further differential expression analysis, we employed a
threshold of p<0.05 and log2>1.8 (3.5 fold change). Since even these stringent parameters
yielded a large number of DEGs, a ranked approach using lists organized by log2 fold change
for up- and down- regulated genes was input for GOrilla and then REVIGO, which performed
gene ontology analysis of differentially expressed genes and removal of redundant GO terms,
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respectively (Eden et al., 2009; Supek et al., 2011). KEGG pathway analysis of DEGs was
analyzed by the Database for Annotation, Visualization and Integrated Discovery (DAVID)
(Huang da et al., 2009). oPOSSUM3 was used in single site analysis (SSA) mode to detect
conserved transcription factor binding sites in significantly differentially expressed genes
(Kwon et al., 2012). The oPOSSUM3 default setting for gene-based analyses was used, in
which all genes in the oPOSSUM database serve as background. The Mixture of Isoforms
(MISO) framework was used for identification of alternatively spliced genes (Katz et al.,
2010). KEGG pathway analysis of differentially spliced genes was also carried out using
DAVID.
Data
Sequence data generated in this study have been made available at SRA. Downstream
analyses

can

be

found

in

the

original

version

of

this

manuscript:

https://pubmed.ncbi.nlm.nih.gov/31136639/.

RT-qPCR
Total RNA was extracted using the PureLink RNA Mini Kit (Thermo Fisher Scientific) and
600ng of RNA was reverse transcribed using Superscript III First-Strand Synthesis SuperMix
(Thermo Fisher Scientific) with random hexamers or gene specific primers according to the
manufacturer’s instructions. qPCR was performed using the Applied Biosystems Step One
Real-Time PCR System. For relative RT-qPCR, RNA levels were normalized to GAPDH and
fold change in expression was calculated using the ∆∆CT method (Livak and Schmittgen,
2001). Quantitative RT-qPCR of the small genome segment was carried out as previously
described and standard curves were generated using in vitro synthesized RNA (Brennan et
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al., 2014). Primers used in this study are as follows listed 5’ to 3’: GAPDH (Qiagen Quantitect
Primer Assay), IFNB: F- AAACTCATGAGCAGTCTGCA, R- AGGAGATCTTCAGTTTCGGAGG,
CXCL10: F- TGGCATTCAAGGAGTACCTCTCT, R- CTGATGCAGGTACAGCGTACG
IFIT2:

F-

TGCACTGCAACCATGAGTGAGAACA,

R-

GCCAGTAGGTTGCACATTGTGGC,

mir210hg: F- GGCAGATTTAGTGGACGCCT, R- CTCACTTCGCAGTGGTGACA, NOG: FGTGCAAGTGCTCGTGCTAGA, R- GCTAGAGGGTGGTGGAACTG

RT-PCR
Validation of alternative splicing events via RT-PCR Primers were designed using PrimerBLAST (Ye et al., 2012), listed here (5’ to 3’): F_RIOK3_Ex5 CCGGTTCCCACTCCTAAAAAGGGC;
R_RIOK3_Ex10

CCAGCATGCCACAGCATGTTATACTCAC;

AGGAAGGTGCAAGAGGTTGG;
CCGGACATTTAGCCGCTCAT;

R_TRA2B_Ex3
R_CLK2_Ex6

TCCGTGAGCACTTCCACTTC;
TGGCCATGGTAGTCAAACCA;

F_TRA2B_Ex1
F_CLK2_Ex3
F_DDX5_Ex11

ATTGCTACAGATGTGGCCTCC;
R_DDX5_Ex12

TGCCTGTTTTGGTACTGCGA;

F_18S_rRNA

GTAACCCGTTGAACCCCATT;

R_18S_rRNA CCATCCAATCGGTAGTAGCG. Cells were infected or mock infected and
harvested after 48 hours, and RNA was isolated via TRIzol. cDNA was generated using 0.1 µg
total RNA, Maxima H Minus reverse transcriptase (ThermoFisher), and random hexamer
primer. The PCR reaction was comprised of 10µl Phusion Flash High-Fidelity PCR Master Mix
(ThermoFisher), 1µl each primer (10mM), 2µl cDNA, and 7µl H2O. Amplification was
achieved with one cycle at 98°C for one minute, and 30 cycles of denaturation at 98°C for one
second followed by paired annealing and extension at 72°C for 15 seconds. RT-PCR reactions
were analyzed via agarose gel electrophoresis.
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Results
Transcriptome profiling and differential expression in RVFV MP-12 infected cells
In the present study, mRNA-seq was performed to compare transcriptomes in RVFV infected
and uninfected HEK293 cells. Cells were either mock-infected or infected with RVFV MP-12
strain at an MOI=0.1 and total RNA was harvested at 48hpi. RVFV MP-12 is an attenuated
vaccine candidate strain that allows viral work to be completed under BSL2 containment
conditions (Vialat et al., 1997). Immunofluorescence and RT-qPCR confirmed that the cells
were broadly infected using this scheme (Figure 1). Poly-A selected RNA from three
biological replicates was used for paired-end library preparation and transcriptome
sequencing on an Illumina HiSeq platform. Approximately 136 million raw reads and 131
million clean reads were generated on average per sample, with phred Q30 values averaging
90.5%. Reads were mapped to the hg19 genome using TopHat2, which resulted in assembly
of >85% of reads across samples (Kim et al., 2013). RVFV mRNAs do not contain poly-A
signals, therefore it was not necessary to map reads to the viral genome, since only
polyadenylated RNAs were used for library generation.

31

Figure 2: RVFV MP-12 infection in HEK293 cells at MOI=0.1. (A) Immunofluorescent detection
of viral nucleocapsid protein in infected and mock-infected cells 48hpi. (B) RT-qPCR absolute
quantification of the viral sense small genome segment at timepoints post-infection. Each point
represents the mean copy number during infections performed in triplicate.
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Differential expression comparison of infected and mock-infected cells was carried out using
the DEGSeq2 R package (Love et al., 2014). A threshold of p<0.05 and log2>1.8 (3.5 fold
change) yields 3125 differentially expressed genes, 2909 upregulated (93%) and 216 (7%)
downregulated genes (Figure 3A). Table 1 represents the top up- and down- regulated genes.
The differential expression analysis was validated via RT-qPCR for 5 genes, 3 upregulated
(CXCL10, IFIT2, IFNB) and 2 downregulated (MIR210hg, NOG) (Figure 3B). Gene expression
during RVFV infection cannot be analyzed without taking into account the role of viral NSs
protein. In infected cells, the 31kDa NSs is present in the cytoplasm as well as in the nucleus,
where it forms filamentous structures mediated by the C-terminal domain (Yadani et al.,
1999). NSs has been shown to suppress transcription on a global level through its interaction
with transcription complex TFIIH components p44 and p62, which inhibits TFIIH complex
assembly by sequestration of p44 and promotes posttranslational degradation of p62 (Le
May et al., 2004; Kalveram et al., 2011). In addition to its role in transcription, TFIIH also
plays roles in cell cycle control and DNA repair (Drapkin et al., 1994; Svejstrup et al., 1995;
Laine et al., 2006). Despite these mechanisms, it is clear that there is an abundance of mRNA
present at the 48h timepoint post-infection. In fact, the number of reads obtained from mock
infected cells was only slightly higher than read count from MP-12 infected cells on average
across the three replicates (S1 Table).
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Figure 3: Differentially expressed genes and associated gene ontology terms at 48hpi. (A)
Volcano plot of DEGs illustrating magnitude cut-off set to log2 fold change of 1.8. DEGs
validated by RT-qPCR are labeled. (B) RT-qPCR confirmation of expression level changes in DEG
analysis. C) GO terms associated with upregulated genes.
Table 2: Top up- and down-regulated genes sorted according to log2 fold change.
Top up-regulated genes
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Gene Symbol

log2 fold change

IFIT2

8.8609

OASL

8.7374

CXCL10

8.1793

IFI44

7.9412

OAS2

7.7257

OAS1

7.4817

MX2

7.3722

C6orf222

7.2838

ITGAM

7.2273

FAP

7.1594

LHFPL3-AS1

7.1383

CCL5

7.1212

SLC2A5

7.1094

IL16

7.0972

PKHD1

6.9233

ANGPT2

6.8649

IFNB1

6.8447

CPA2

6.8341

CGA

6.8093

IFIH1

6.7032

Top down-regulated genes
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Gene symbol

log2 fold change

MIR210HG

-3.9125

NOG

-3.7649

OR51E2

-3.2826

RP6-24A23.7

-3.2239

RP11-214O1.2

-3.1586

ZNF346-IT1

-3.1292

KIF12

-3.0213

IRS4

-2.999

C1orf95

-2.9308

RP11-355I22.7

-2.8618

IGFBP5

-2.8572

RP11-250B2.3

-2.7806

KCNA2

-2.7728

AC074212.5

-2.7277

RP11-148O21.6

-2.7234

RP11-148O21.3

-2.6813

POSTN

-2.6773

KDM5B-AS1

-2.6659

HILPDA

-2.6617

RP11-148O21.4

-2.6528
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Upregulated genes are in good agreement with those from a transcriptome profiling study
performed by Pinkham and colleagues with both MP12 and ZH548 strains of RVFV over a
shorter 18hr time-course of infection in HSEAC cells (Pinkham et al., 2017). Their study
showed that the most highly upregulated genes during both MP12 and ZH548 infection were
ISGs (interferon stimulated genes). The two most highly upregulated genes at 18hpi were
interferon stimulated genes (ISGs) IFIT2 and OASL, and in our study at 48hpi those were also
the top upregulated transcripts. Additional ISGs upregulated at 48hpi include the other 2’-5’
oligoadenylate synthase (OAS) family members OAS1 and OAS2, IFI44, MX2, IFNB1 and
IFIH1/MDA5. Many inflammatory cytokines and chemokines were also activated (CXCL10,
CCL5, IL16, ANGPT2, CXCL11). Tripartite motif containing 22 (TRIM22) was also highly
upregulated, and has previously been shown to play an important role in antiviral immunity
during Influenza A virus (IAV) infection due to its ability to target the IAV nucleoprotein for
degradation (Di Pietro et al., 2013). Other upregulated genes were involved in cell adhesion
(ITGAM) and microtubule motor activity (DNAH12), Wnt signaling (FAP), membrane
transport (SLC2A5, NPC1L1, LAT2), metabolism (CPA2, PYGM) and apoptosis (XAF1).

Downregulated genes comprised genes involved in a diverse array of cellular functions. The
most highly downregulated gene was MIR210HG, a microRNA that is upregulated in several
cancers and is critical for regulating the hypoxic response (Fasanaro et al., 2009; Bavelloni
et al., 2017). The hypoxia-induced lipid droplet associated HILPDA was also highly
downregulated in our study and the study by Pinkham and colleagues. Downregulation of
these factors is interesting, since RVFV infection stimulates oxidative stress (Narayanan et
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al., 2011). In addition to its role in altering host cell transcription, virulence factor NSs is also
known to interact with the mitochondria leading to redox imbalance and reactive oxygen
species production, which leads to activation of NF-κB (p65) and p53 (Narayanan et al.,
2014). Ionotropic glutamate receptors (GRIA3, GRID2), a potassium-voltage gated channel
(KCNA2), kinesin family member 12 (KIF12), and several long noncoding RNAs (RP11214O1.2, RP11-355I22.7, RP11-250B2.3, RP11-148O21.6, AC083843.1) were also
significantly downregulated.

Gene ontology and KEGG pathway analysis
Gene ontology (GO) analysis of differentially expressed genes was performed using GOrilla,
which allows the user to input a ranked list of target genes for analysis, and redundant GO
terms were removed using REVIGO (Eden et al., 2009; Supek et al., 2011). Using GOrilla for
a large list of genes, input of genes ranked by their log2 fold change values outputs GO terms
more significantly enriched in highly differentially expressed genes. GO analysis of
upregulated genes using a single ranked list of genes and a p-value threshold of 10-3
illustrates, as expected, that the immune response is highly enriched upon infection as well
as cell surface receptor signaling and signal transduction (Figure 3C). The much shorter list
of downregulated genes showed no significant enrichment using the same parameters.

KEGG pathway analysis using DAVID for all significantly differentially expressed genes
indicated that several pathways, inclucing many pathways involved in the type I IFN
response (NF-κB signaling, TNF signaling, toll-like receptor signaling, RIG-I like receptor
signaling, cytosolic DNA-sensing) were transcriptionally modified post-infection (Table 2).
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As is the case with canonical type I IFN activation, it appears that IFN signaling activated the
JAK/STAT pathway, which in turn upregulated interferon stimulated genes (ISGs). Pathway
analysis also showed robust activation of the cytokine-mediated inflammatory response
(cytokine-cytokine receptor interaction, chemokine signaling, NOD-like receptor signaling).
Linoleic and Arachidonic acid metabolism pathways were also altered, which could indicate
that arachidonic acid-derived eicosanoids influenced the immune and inflammatory
response during RVFV infection, as has been previously discovered for respiratory viruses
(McCarthy and Weinberg, 2012). PI3K/AKT/mTOR signaling was also altered upon
infection, consistent with prior work that showed RVFV infection attenuates Akt and
downstream mTORC1 activity (Moy et al., 2014; Hopkins et al., 2015). Lastly, extracellular
matrix (ECM) -receptor interaction pathways were modified during infection. Further
investigation of the involvement of ECM receptor signaling during infection could yield
insight into viral entry and cell to cell spread, which is an understudied area for RVFV.

Table 3: KEGG pathways analysis of differentially expressed genes.
KEGG Pathway

p-value

Cytokine-cytokine

receptor

interaction
Complement

2.80E-14
and

coagulation

cascades

2.40E-05

Jak-STAT signaling pathway

2.70E-05

ECM-receptor interaction

2.00E-04
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NF-kappa B signaling pathway
Neuroactive

2.00E-04

ligand-receptor

interaction

2.20E-04

Protein digestion and absorption

2.30E-04

Linoleic acid metabolism

6.90E-04

Hematopoietic cell lineage

4.10E-03

Chemokine signaling pathway

4.20E-03

Toll-like receptor signaling pathway

5.80E-03

Osteoclast differentiation

6.00E-03

TNF signaling pathway

6.40E-03

Arachidonic acid metabolism

7.10E-03

Phenylalanine metabolism

1.40E-02

Calcium signaling pathway

1.70E-02

Fat digestion and absorption

2.00E-02

NOD-like receptor signaling pathway

2.60E-02

Cytosolic DNA-sensing pathway

2.60E-02

Leukocyte transendothelial migration

2.70E-02

Phototransduction

2.90E-02

Steroid hormone biosynthesis

3.20E-02

Tyrosine metabolism

3.30E-02

PI3K-Akt signaling pathway

3.60E-02

Serotonergic synapse

3.80E-02

40

Transcriptional

misregulation

in

cancer
Natural

4.20E-02
killer

cell

mediated

cytotoxicity

4.40E-02

RIG-I-like receptor signaling pathway

4.60E-02

Changes in host alternative splicing during viral infection
Alternative splicing (AS) of pre-mRNAs is a critical mechanism for regulating gene
expression and expanding proteome diversity. Recent studies indicate that viral infection
can cause marked changes in host splicing patterns, which results from the altered posttranscriptional program undertaken by the host as a response to invasion, but many viruses
have also evolved methods to interfere with and modulate host splicing (Batra et al., 2016;
Boudreault et al., 2016; Han et al., 2018). To determine whether AS might play a role in RVFV
pathogenesis, we examined differences in splicing patterns between MP12 infected and
uninfected cells using MISO (Mixture of Isoforms), which estimates differential spliced
isoform expression and confidence intervals using Y values and Bayes factors, respectively
(Katz et al., 2010). Analysis yielded 1499 differential AS events between infected and
uninfected cells using threshold Y of >0.2 and BF >10. MISO categorizes isoforms as being
one of five different splicing event types: alternative 5’ splice site selection (A5SS),
alternative 3’ splice site selection (A3SS), mutually exclusive exons (MXE), retained introns
(RI), and skipped exons (SE). The analyses yielded SE events as the dominant splicing pattern
at 783 events, which is just over half the total number of events (Figure 4A). Additionally,
analyses revealed 275 RI, 168 A3SS, 137 A5SS and 136 MXE events (Figure 4A). While most
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genes had only one event per gene (n=979), there were many genes that had multiple AS
events per gene. These include GUSBP11 with 7 events, EEF1D and TRA2A with 6 events,
WASH7P with 5 events, and 216 genes with 4, 3 or 2 events.

A)

B)
RIOK3: Increased A5’SS Selection

TRA2B: Decreased SE

MP12

Mock

Mock MP12

MP12

Mock

Mock MP12

Expected size: 812bp Normal Site; 669bp Alternative Site

Expected size: 416bp Spliced In; 140bp Skipped

CLK2: Increased SE

DDX5: Decreased RI

MP12

Mock

Mock MP12

MP12

Mock

Mock MP12

Expected size: 272bp Spliced In; 184bp Skipped

Expected size: 1369bp Intron Retained;
133bp Spliced In

18S rRNA

Figure 4: Alternative splicing events induced by viral infection. (A) Significant AS events in
infected compared with mock-infected cells. Splicing pattern types identified by the MISO
algorithm are shown. (B) Verification of AS events using RT-PCR with PCR primers flanking the
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spliced region. IGV was used to visualize mRNA-seq transcripts and the vertical axis represents
the quantity of mapped reads for each condition. Red arrows indicate the primer amplicon
region, except for RIOK3, where a larger region was amplified between exons 5 and 10.

Several splicing events were validated via RT-PCR using primers flanking the splicing events
of interest (Figure 4B). These events also produced interesting changes in the mRNA
transcripts that would result in intriguing functional outcomes. For example, Rio kinase 3
(RIOK3) undergoes alternative 5’ splice site selection in exon 8 in infected cells, which
generates a frameshift and introduces a premature termination codon in exon 9. This
truncated RIOK3 transcript could be a target for nonsense mediated decay, or, if it were
translated, it would be predicted to produce a C-terminally truncated protein product that is
lacking almost the entire kinase domain. Interestingly, RIOK3 has been implicated as an
important player in the host antiviral response and thus this splicing event could have
important regulatory consequences for these pathways post-infection (Feng et al., 2014;
Takashima et al., 2015).

Transformer 2 beta homolog (TRA2-b) exhibits decreased exon 2 skipping in infected cells.
This demonstrates incidence of an autoregulatory splicing event that has been previously
characterized. TRA2-b is a serine-arginine splicing factor responsible for altering splice site
selection in a variety of transcripts in a concentration dependent manner. As is the case with
most splicing factors, their expression must be tightly regulated, as misregulation is
associated with various disorders. TRA2-b uses a negative feedback autoregulatory
mechanism to activate inclusion of its own exon 2. Inclusion of exon 2 generates a longer
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splice variant which encodes a “poison exon” that introduces a premature stop codon,
causing the transcript to be degraded by nonsense-mediated decay (Stoilov et al., 2004a). In
infected cells, the decreased incidence of exon 2 skipping corresponds with production of
the poison exon isoform, perhaps the result of high TRA2-b protein expression regulating its
own splicing and downstream expression, or another splicing factor disequilibrium causing
reduced TRA2-b expression.

Similar to TRA2-b, CDC-like kinase 2 (CLK2) also autoregulates its protein expression by
promoting skipping of its own exon 4. This event generates a frameshift which renders the
CLK2 mRNA transcript a target of the nonsense-mediated decay machinery and is thus not
translated into functional protein (Hillman et al., 2004; Glatz et al., 2006). In infected cells
there is an increase in exon 4 skipping, which appears to indicate that these CLK2 transcripts
are not translated. Lastly we validated the decrease in intron retention noted during viral
infection, which occured in DEAD-box helicase 5 (DDX5) between exons 11 and 12.
Interestingly, this intron is highly conserved and variably included in DDX5 transcripts
across tissues, indicating an important functional role (Stevenson et al., 1998; Rossler et al.,
2000). Indeed, the intron has been shown to encode a processed miRNA that
coimmunoprecipitates with Ago2, although endogenous targets have yet to be characterized
(Moore et al., 2011).

Alternative splicing occurs through splicing factors, RNA-binding proteins known which can
bind introns or exons and work as splicing silencers or splicing enhancers (MartinezContreras et al., 2007; Long and Caceres, 2008). We wondered whether splicing factor
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abundance was altered during viral infection, either by the host cell or by RVFV. First, we
filtered our DEG results using a list of experimentally-determined splicing factors (Giulietti
et al., 2013), defined as RNA-binding proteins which recruit or block the spliceosome at a
particular splice site. Splicing factors can be further categorized as SR splicing factors (which
are typically splicing enhancers), heterogeneous nuclear ribonucleoproteins (hnRNPs,
which are typically splice silencers), and others which fall into neither of these categories. In
RVFV-infected cells, splicing factors were both differentially expressed and alternatively
spliced; 49 out of 68 splicing factors were significantly upregulated or downregulated in
RVFV-infected cells (Figure 5A), 12 splicing factors were alternatively spliced (Figure 5B),
and 9 were both differentially expressed and alternatively spliced. Interestingly, SR splicing
factors, of which the aforementioned TRA2-b is a member, are often regulated through
alternative splicing networks, where one splicing factor regulates the splicing of exons in its
own mRNA or the mRNA of other splicing factors (Leclair et al., 2020). They do so by splicing
in poison exons, which cause a premature stop codon, and transcripts are degraded through
nonsense-mediated decay, which may account for the decreased expression in some of the
splicing factors. It is likely that alteration of these splicing networks may be initiated by
direct interference by the virus or by host innate immune programs.
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significantly differentially expressed
splicing factor trancripts

B)

hnRNPs

SR splicing factors

ELAVL3
SRSF7
PTBP2
TRA2A
SFPQ
SF1
TRA2B
SRSF6
KHSRP
SRRM1
HNRNPM
HNRNPH3
FUS
ELAVL2
SRSF10
HNRNPF
FMR1
HNRNPH1
TIAL1
YBX1
ELAVL1
SRSF3
HNRNPK
SRSF9
RBM5
PCBP2
HNRNPL
KHDRBS1
RBM25
SYNCRIP
HNRNPC
KHDRBS3
TARDBP
SRSF5
ESRP1
SRSF4
HNRNPD
PCBP1
HNRNPA0
HNRNPA2B1
TIA1
HNRNPH2
ZRANB2
QKI
HNRNPA1
HNRNPA3
RBFOX2
NOVA1
NOVA2

significant alternative splicing events
in splicing factor transcripts
TRA2A

skipped exon

TRA2A

skipped exon

TRA2A

skipped exon

TRA2A

skipped exon

TRA2A

mutually exclusive exon

TRA2A

retained intron

TRA2A

retained intron

TRA2B

skipped exon

SRSF11

skipped exon

SRSF11

alternative 3’ splice site

HNRNPC

alternative 3’ splice site

HNRNPC

mutually exclusive exon

HNRNPD

skipped exon

HNRNPH1

alternative 5’ splice site

HNRNPH3

retained intron
skipped exon

PTBP1

alternative 3’ splice site
skipped exon

MBNL1

0.
4

0.
2

retained intron

-0
.0

retained intron

TIAL1

-0
.2

SF1

-0
.4

Others

FMR1

4

2

Change in PSI between
mock- and MP-12-infected cells

0

-2

Splicing Factor

A)

Log2 fold change between
mock- and MP-12-infected cells

Figure 5: Differentially expressed and alternatively spliced splicing factors in RVFV-infected
cells. (A) Log2 fold change of splicing factors that were significantly differentially expressed in
RVFV-infected cells compared to mock. (B) Change in PSI for splicing factors that were
alternatively spliced in RVFV-infected cells compared to mock, organized by family of SFs.

Most spliced genes were not differentially expressed at the level of transcription, indicating
that differential expression and AS are independent regulatory mechanisms occurring postinfection (Figure 6A). In order to understand the functional consequences of these splicing
events, we implemented GO enrichment analysis using all AS genes. GO terms with p-values
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of <0.05 were subjected to Revigo in order to cluster and delete redundant GO terms. REVIGO
scatterplot analysis shows that most AS genes are involved in cellular metabolic and
biosynthetic processes, as well as RNA processing (Figure 6B). KEGG pathways significantly
enriched amongst AS genes were mRNA surveillance pathway, Fanconi Anemia pathway,
Hippo signaling, and RNA transport.

47

Figure 6: Expression and GO analysis of alternatively spliced transcripts. (A) Alternative
splicing events plotted with Bayes factor represented on the y-axis and differential expression
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on the x-axis. (B) REVIGO scatterplot analysis of overrepresented GO terms associated with AS
genes. The two-dimensional plot clusters GO terms based on semantic similarities. Bubble color
corresponds to the p-value; size indicates the frequency of the GO term within the database.

Discussion
This study has detailed the transcriptional modifications and splicing events that occur in
RVFV MP-12-infected HEK293 cells using a broad infection scheme. We demonstrate that
many genes are differentially expressed and we identify GO and KEGG pathways as well as
differentially expressed and spliced splicing factor mRNA. One of the main themes that
appeared in this analysis was activation of innate immunity and inflammation. ISGs
comprised a majority of top up-regulated genes, and we confirmed an increase in several of
these genes using RT-qPCR. In addition, KEGG pathways associated with DEGs included NFkB signaling, TNF signaling, toll-like receptor signaling, RIG-I like receptor signaling,
cytosolic DNA-sensing, JAK-STAT signaling, cytokine-cytokine receptor interaction,
chemokine signaling, NOD-like receptor signaling.

Several studies have highlighted the importance of the antiviral response in determining
viral pathogenesis and disease outcome as a result of RVFV infection (McElroy and Nichol,
2012; Wonderlich et al., 2018). Age-associated susceptibility to RVFV has been
demonstrated in humans, livestock and laboratory animals, which suggests that host
resistance may be mediated by the more robust type I interferon system present in mature
adults (Bird et al., 2009; Elliott and Weber, 2009). Like most negative-sense RNA viruses,
RVFV does not produce significant levels of dsRNA during infection (Weber et al., 2006).
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Nevertheless, RVFV activates PKR, and the 5’ triphosphate groups present at the RVFV
genome termini act as a strong activators of RIG-I-dependent interferon induction,
culminating in ISG induction (Habjan et al., 2008; Habjan et al., 2009). Despite the fact that
NSs is a powerful inhibitor of PKR signaling and IFNB promoter activation, our work shows
that host cells still mount a significant antiviral response by 48hpi. Another study on global
transcriptome profiling during Schmallenberg virus infection (SBV) showed dampened
activation of IFN stimulated genes in SBV infection as opposed to infection with SBV lacking
the NSs gene (Blomstrom et al., 2015). However, similar to the results shown here, their
work also indicated that some antiviral genes escape NSs suppression during SBV infection.

It has been previously shown that NSs acts as a global inhibitor of transcription via its
interaction with TFIIH complex components and by binding with SAP30 to prevent IFNB
promoter activation (Le May et al., 2008). Surprisingly, we noticed only a modest decrease
in total reads obtained from MP-12 infected cells when compared with mock-infected cells,
and most genes in the DEG analysis were actually upregulated during infection. A similar
trend was observed in a prior study during mRNA-seq analysis comparing MP-12 and ZH548
strains of RVFV in HSEACs at timepoints post-infection, where it was noted that, although
the differences were not statistically significant, fewer reads were obtained during later
times post-infection, and DEG analysis at 18hpi yielded more upregulated than
downregulated genes (Pinkham et al., 2017). Their study did, however, support the role of
NSs as a general inhibitor of transcription, since RT-qPCR analysis of several housekeeping
genes at 9 and 18 hpi exhibited decreased expression relative to mock infected cells.
Chromatin immunoprecipitation with promoter sequence microarray analysis of NSs
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showed that several promoter regions interacted with NSs and that the interaction
correlates with decreased expression of the corresponding genes, with the notable exception
of genes associated with the coagulation cascade, which actually exhibited increased
expression as a function of NSs binding (Benferhat et al., 2012). Interestingly, KEGG analysis
in our study indicated alteration in the complement and coagulation pathway at 48hpi,
possibly corroborating the ability of NSs to stimulate transcription of some gene categories.
While certain families of genes were overrepresented among NSs interaction regions in the
ChIP study, NSs only specifically interacted with about 10% of promoter regions represented
in the array (Benferhat et al., 2012). It is possible that at later timepoints post-infection, host
antiviral response gene production is in such overdrive that it masks the transcriptional
inhibition ability of NSs which may be more effective at earlier timepoints post-infection.
Furthermore, mRNA-seq analysis at 48hpi represents a single snapshot in time, not
providing any information to distinguish between newly transcribed mRNAs and mRNAs
that are still present due to a longer half-life or regulation by mRNA decay mechanisms. A
detailed study with multiple timepoints post-infection, as well as incorporating an infection
scheme using an NSs-deletion mutant virus could aid in our understanding of the role of NSs
in transcription.

Our analysis also showed that a surprising array of mRNA transcripts are alternatively
spliced during infection. Preliminary analysis and validation of several events indicated that
these are programmed events that have been previously characterized and have functional
consequences for gene expression, as opposed to abberant events that could be construed as
a byproduct of cellular disarray due to infection. Alternative splicing events occurring during
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infection were primarily in genes with GO terms related to RNA processing, and this was
evident in the validated splicing events. Notably, DDX5, TRA2-b and CLK2 all play important
roles in RNA splicing and gene expression. For these three genes, the alternative splicing
patterns adopted during infection yielded transcripts that have been previously shown to be
non-functional. Alternative splicing is appreciated widely as a mechanism for expanding
genetic economy and proteome diversity. However, the coupling of alternative splicing with
RNA decay pathways is also an important mechanism by which the cell can posttranscriptionally control gene expression. Although not extensively studied to this point, it
is possible that this is an important mechanism adopted by the cell to fine-tune gene
expression in the wake of viral infection. It is also important to acknowledge that viruses
have adopted multifarious methods to thwart or hijack host RNA transcription, splicing,
processing and decay. A role for RVFV in interference with host splicing has not yet been
described, but because RVFV nucleocapsid binds host RNA and enters the nucleus (Hayashi
et al., 2021), it could be a method of viral interference to occlude splice sites. As more
transcriptome profiling studies are conducted during viral infection, it will be of great
interest to examine the global splicing environment in order to better understand the host
and viral mechanisms at play.

Lastly, RVFV-infected cells exhibited increased expression of a truncated splice isoform of
atypical protein kinase RIOK3. RIOK3’s role in the cell is unclear, as there is controversy in
the literature regarding whether it is involved in activation (Feng et al., 2014) or inhibition
of (Takashima et al., 2015) innate immunity against viral infection. The shorter isoform of
RIOK3 had not been annotated prior to this work, and if it is translated, it would be missing
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much of its RIO domain, the putatively functional domain which shares homology with
RIOK1 and RIOK2. We hypothesize that this alternative splicing is either a regulatory
mechanism by the host cell to restrict innate immunity after it is activated or an antiviral
avoidance mechanism used by the virus. More research into RIOK3’s apparently
contradictory function in the cell will be important for understanding its relationship with
innate immunity and RVFV.

In conclusion, this study provides a transcriptomic perspective of RVFV-infected HEK293
cells after two days of infection. Despite the powerful ability of NSs to derail the host immune
response via inhibition of the IFNB promoter as well as NSs-driven PKR degradation, we
have illustrated that the cell still mounts a robust antiviral response at this late timepoint
post-infection. We further illustrate that functionally related groups of transcription factor
binding sites were represented in DEGs, highlighting specific cellular priorities at this point
during infection. Future transcriptome profiling studies incorporating an infection scheme
with an NSs deletion MP-12 strain and a nonviral innate immune stimulant such as poly I:C
would better discern the effects of NSs and the innate immune response, respectively. In
addition, this is the first study to characterize significant global splicing changes that occur
in RVFV infected cells, including confirmation of events that lead to non-productive
trancripts. This emphasizes the importance of future studies addressing the functional
consequences of the splicing overhaul that occurs as a result of infection.
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Chapter 3: The atypical kinase RIOK3 limits RVFV propagation
and is regulated by alternative splicing
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Abstract
In recent years, transcriptome profiling studies have identified changes in host splicing
patterns caused by viral invasion, yet the functional consequences of the vast majority of
these splicing events remain uncharacterized. We recently showed that the host splicing
landscape changes during Rift Valley fever virus MP-12 strain (RVFV MP-12) infection of
mammalian cells. Of particular interest, we observed that the host mRNA for Rio Kinase 3
(RIOK3) was alternatively spliced during infection. This kinase has been shown to be
involved in pattern recognition receptor (PRR) signaling mediated by RIG-I like receptors to
produce type-I interferon. Here, we characterize RIOK3 as an important component of the
interferon signaling pathway during RVFV infection and demonstrate that RIOK3 mRNA
expression is skewed shortly after infection to produce alternatively spliced variants that
encode premature termination codons. This splicing event plays a critical role in regulation
of the antiviral response. Interestingly, infection with other RNA viruses and transfection
with nucleic acid-based RIG-I agonists also stimulated RIOK3 alternative splicing. Finally, we
show that specifically stimulating alternative splicing of the RIOK3 transcript using a
morpholino oligonucleotide reduced interferon expression. Collectively, these results
indicate that RIOK3 is an important component of the mammalian interferon signaling
cascade and its splicing is a potent regulatory mechanism capable of fine-tuning the host
interferon response.
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Introduction
Rift Valley Fever Virus (RVFV) is a mosquito-borne, negative sense RNA virus that belongs
to the Phlebovirus genus within the Phenuiviridae family (Adams et al., 2017) that infects
humans and livestock animals in Africa and the Arabian Peninsula. In humans, it can cause
illness ranging from mild flu-like symptoms to hemorrhagic fever, blindness, liver disease,
and death (Ikegami and Makino, 2011). In livestock, RVFV infection results in a high
mortality rate among young animals, and causes “abortion storms” in which nearly all
infected pregnant animals will have aborted pregnancies (Coetzer and Tustin, 2004).
Additionally, infection by RVFV in humans may lead to increased miscarriage rates (Baudin
et al., 2016). It is currently categorized as a Category A pathogen and a select agent by the
USA Centers for Disease Control, and no vaccines or drugs have been approved for human
use in the general population. Therefore, it is important to understand the molecular
virology of RVFV in order to develop effective antiviral therapeutic strategies. Here we
describe a host factor, RIOK3, whose activity is antagonistic to propagation of RVFV MP-12,
an attenuated vaccine candidate strain, and whose activity is modulated in cells via
alternative splicing.

Alternative splicing (AS) is an important post- and co- transcriptional regulatory mechanism
that influences the expression of more than 95% of genes in the human genome (Wang et al.,
2008). Genetic coding capacity is expanded by AS, making it one of the primary mechanisms
generating diversity between the genetic code and the proteome (Stamm et al., 2005). AS
allows the production of structurally diverse protein isoforms from a single gene, and can
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contribute to regulation of gene expression via its functional association with nonsensemediated decay (NMD) (Lewis et al., 2003; Chang et al., 2007).

Programmed changes in splicing patterns occur during embryonic development and
maturation, as a consequence of disease, or as a response to changes in the external
environment (Tazi et al., 2009; Baralle and Giudice, 2017; Richards et al., 2017). Prior work
in our laboratory, as well as the work of others, has shown that widespread alteration in host
alternative splicing patterns follow viral infection (Sessions et al., 2013; Boudreault et al.,
2016; Havranek et al., 2019). However, very little is known about how cellular splicing
changes impact the outcome of viral infection. Here, we investigate a particular host gene,
Rio kinase 3 (RIOK3), which we discovered to be alternatively spliced following RVFV MP12 infection of HEK293 cells. RIOK3 was particularly intriguing since two previous studies
suggested it is involved in the innate immune response that is important for controlling viral
infection (Feng et al., 2014; Takashima et al., 2015). Furthermore, a recent report
demonstrated that translation of RIOK3 is enhanced by an unusual mechanism involving
methylation of the RIOK3 mRNA during flaviviral infection (Gokhale et al., 2020), which
supports the ideas that RIOK3 is both an important component of the cellular response to
infection, and a potential target for viral countermeasures against the cellular responses to
infection.

MDA5 and RIG-I are RIG-I-like receptors (RLRs), which function as pattern recognition
receptors (PRRs) that sense foreign RNA in the cytoplasm and transduce a signaling cascade
to induce downstream type I interferon (IFN) production and the antiviral response (Kato et
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al., 2006). RIOK3 was recently implicated in phosphorylation of the C-terminus of MDA5,
which would inhibit MDA5 filament formation and prevent its interaction with MAVS,
effectively quenching downstream signaling (Takashima et al., 2015). A separate report
showed that RIOK3 acts as an adaptor protein that mediates the interaction between IRF3
and TBK1 downstream of PRR activation, which is critical for type I IFN induction following
viral infection (Feng et al., 2014). Thus, these two studies suggest that RIOK3 can act in dual
roles, either stimulating or inhibiting innate immune activation. Notably, the experimental
systems employed were different, and because different viruses activate distinct PRRs, the
different roles for RIOK3 may depend on the pathway initially activated (Habjan et al., 2008).
In any case, the clearly important roles of RIOK3 during viral infection warrants additional
investigation.

In this study, we show that RIOK3 knockout led to increased RVFV MP-12 titer and mitigated
downstream stimulation of IFN production. We also show that RIOK3 complementation in
RIOK3 CRISPR/Cas9 knockout cells rescued production of IFN. Furthermore, in response to
viral infection, cells produced alternatively spliced mRNA variants that were targeted by the
nonsense-mediated decay machinery. Interestingly, transfection with the pan-RLR agonist,
poly (I:C), and the RIG-I specific agonist, 3p-hpRNA, also triggered AS of RIOK3. Together,
these data suggest that RIOK3 is an activator of the innate immune response and that its
expression/activity is fine-tuned by alternative splicing in a likely auto-regulatory feedback
loop.
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Materials and Methods
Viruses, Cell Culture and Infections
The MP-12 vaccine strain of RVFV was kindly provided by Brian Gowen (Utah State
University, Logan, UT, USA) and the rLuc RVFV reporter virus (also called delNSsrLuc MP12), derived from MP-12 and containing the gene for Renilla luciferase in place of the viral
NSs gene, was provided by Richard Elliott and Benjamin Brennan (University of St. Andrews,
United Kingdom). Tacaribe virus (strain TRVL 11573) was a gift from Jack Nunberg
(University of Montana), and the GFP-expressing adenovirus strain (admax-eGFP) and
HCMV (strain TR) were gifts from Brent Ryckman (University of Montana). Sindbis virus
(strain EgAr 339, NR-15695) was obtained through BEI Resources, NIAID, NIH.
Manipulations of the viruses used in this study are compliant with both the Institutional
Biosafety Committee at the University of Montana, Missoula, and NIH requirements in regard
to their handling under BSL2 containment conditions (Caplen et al., 1985).

HEK293 cells and Vero cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM)
with 10% fetal bovine serum and penicillin/streptomycin. For experiments using RVFV MP12 or rLuc RVFV, 80–90% confluent HEK293 cells were washed with phosphate-buffered
saline (PBS) and overlaid with virus at the specified multiplicity of infection (MOI) in DMEM
without serum or antibiotics and incubated for one hour at 37 °C and 5% CO2. After
incubation with virus the media was replaced with DMEM with 10% fetal bovine serum and
penicillin/ streptomycin and the cells were maintained at 37 °C and 5% CO2 until time of
harvest. For TCRV infections, 80–90% confluent HEK293 cells were washed with PBS and
overlaid with TCRV inoculum in DMEM without serum or antibiotics sufficient to produce
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significant (~80%) CPE within 24 h of infection. After initial incubation with TCRV for 2 h,
the media was replaced with DMEM with 10% fetal bovine serum and 1% penicillin/
streptomycin and the cells were maintained at 37 °C and 5% CO2 for 24 h. For ADV infections,
80–90% confluent HEK293 cells were washed with PBS and overlaid with ADV stock at an
MOI of 10 (as titered by prior plaque assay) in DMEM without serum or antibiotics and
incubated for one hour at 37 °C and 5% CO2, after which the media was replaced with DMEM
with 10% fetal bovine serum and penicillin/ streptomycin and the cells were maintained at
37 °C and 5% CO2 for 24 h.

Plasmids and Cloning
The RIOK3 open reading frame was PCR amplified from Addgene plasmid #20618 (pWZL
Neo Myr FLAG), which was a gift from William Hahn and Jean Zhao (Dana-Farber Cancer
Institute, Boston, MA, USA) (Boehm et al., 2007). The RIOK3 ORF was cloned into phRL-CMV
(Promega) between the XbaI and NheI restriction sites. The X2 variant was PCR amplified
from cDNA obtained from infected HEK293 cells and was also cloned into phRL-CMV
between the XbaI and NheI restriction sites. The pGL3-IFNB plasmid was obtained from
Addgene, plasmid #102597 (IFN-Beta_pGL3), which was a gift from Nicolas Manel (Institut
Curie, Paris, France) (Gentili et al., 2015).

Transfection
Plasmid transfections were performed on HEK293 cells using Lipofectamine 2000 as per the
manufacturer’s instructions (Thermo Fisher Scientific, Waltham, USA). RIOK3 and GFP
control FlexiTube siRNAs (Qiagen (Germantown, USA) nos. Hs_RIOK3_4 and Hs_RIOK3_8)

60

and HiPerFect Transfection Reagent were used for siRNA knockdown experiments in
HEK293 cells according to the manufacturer’s instructions. HEK293 cells lack TLR3
expression for stimulation of innate immunity via poly (I:C) added to culture media.
Therefore, we transfected the RLR ligands. We used poly (I:C) to stimulate both the MDA5
and the RIG-I pathways, and 3p-hpRNA, which stimulates only the RIG-I pathway. we
transfected 1 μg/mL poly (I:C) (Tocris/BioTechne, Minneapolis USA) or 3p-hpRNA
(Invivogen, San Diego, USA) into HEK293 cells using Lipofectamine 2000 according to the
manufacturer’s instructions (Thermo Fisher Scientific). Morpholino oligos (Gene-Tools,
Philomath, USA) were transfected using Endo-Porter according to the manufacturer’s
instructions (Gene-Tools).

Western Blotting
Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer with protease inhibitors
(10 mM Tris-HCl pH 8.0, 140 mM NaCl, 1mM EDTA, 0.5mM EGTA, 1% Triton X-100, 0.1%
sodium deoxycholate, 0.1% SDS). Clarified lysates were separated by SDS-PAGE on 10%
polyacrylamide and wet transferred to PVDF. The membrane was blocked with 2.5% dry
milk solution in Tris-buffered saline Tween 20 (TBST) at room temperature. Primary
antibodies used include: Monoclonal M2 anti-FLAG (MilliporeSigma, Burlington, USA),
GAPDH loading control antibody MA5-15738 (Thermo Fisher Scientific), anti-RIOK3
SAB1406721 (Sigma). Following primary antibody incubation, the membrane was triple
rinsed in TBST. HRP- conjugated secondary antibody used was anti-Mouse IgG peroxidase
antibody produced in goat A2554 (Sigma). Following secondary antibody incubation, the
membrane was triple rinsed with TBST. Chemiluminescent visualization of blots was carried
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out using Pierce ECL Western Blotting Substrate (Thermo Fisher Scientific) and a Fujifilm
LAS 3000 imager.

Plaque Assays
HEK293 cells were treated with siRNA and infected with MP-12 (1.0 M.O.I.) as previously
described. Supernatants were collected 24 hpi and titered via plaque assay. For plaque
assays, Vero cells were grown to 90–100% confluence, washed with PBS, and overlaid with
dilutions of virus in serum and antibiotic free DMEM, and infections were carried out as
described above. Infected cells were overlaid with 3mL of a 1:1 solution of 2% sterile lowmelting agarose and 2× Eagle’s Minimal Essential Medium (2× MEM). Once solidified, plates
were incubated at 37 °C and 5% CO2 for 6 days. After 6 days, agar overlays were discarded
and the fixed cells were stained with crystal violet.

Luciferase Reporter Assays
For Renilla luciferase assays, HEK293 cells were either treated with RIOK3 or control siRNA,
or transfected with either full-length RIOK3 cDNA or GFP expressing plasmids, and infected
with rLuc RVFV (MOI of 1; measured by flow cytometry nucleocapsid protein positive
staining cells at 24 hpi). Renilla luciferase activity was measured and assessed using the
Renilla Luciferase Assay System (Promega, Madison, USA) according to the manufacturer’s
instructions. For dual luciferase reporter assays, HEK293 cells were co-transfected with
pGL3-IFNB firefly reporter and a 1:10000 dilution of phRL-CMV Renilla control plasmid. 24
h post transfection, cells were infected with MP-12 (MOI of 1; titer measured by flow
cytometry quantifying nucleocapsid protein positive cells at 24 hpi) or transfected with poly
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(I:C). At 48 hpi or 18 h post transfection, cells were assayed for dual luciferase activity using
the Dual luc HT assay kit (GeneCopoeia, Rockville, USA).

CRISPR/Cas-Mediated Genome Editing
The expression of full length, X1, X2, or X1/X2 transcript isoforms from the RIOK3 gene in
HEK293 cells was knocked-out in both alleles by CRISPR/Cas-mediated genome editing (RIO
Kinase 3, gene ID: 8780, Ensembl: ENSG00000101782). Briefly, three distinct guide RNA
were designed using the online resources of the Zhang lab (https://zlab.bio/guide-designresources). The concurrent use of three guide RNAs maximizes the chance of obtaining a
knock-out cell clone. The best targets close to the start codon of the full length RIOK3
transcript were located in exons 3, 4, and 5 (exon 3 guide, plus strand,
TACTTCCAGTGACCTTATGC-TGG; exon 4 guide, minus strand, GAGCTATCGCTGTCTTCATAAGG; exon 5 guide, plus strand, ACCGGTTCCCACTCCTAAAA-AGG). Three DNA fragments
(gBlocks, Integrated DNA Technologies, Coralville, Iowa) bearing a single guide RNA
sequence were each inserted in the pL-CRISPR.EFS.PAC plasmid, a gift from Benjamin Ebert
(Addgene plasmid #57828; http://n2t.net/addgene: 57828; RRID: Addgene_57828) (Heckl
et al., 2014). Sanger sequencing validated the exactness of the three individual plasmid
constructs.

An equimolar mix of the three plasmids was then transfected in a fresh culture of HEK293
cells by the calcium phosphate precipitation method. The Cas9 enzyme is expressed in the
transfected cells since the pL-CRISPR.EFS.PAC plasmid bearing the guide RNA genes also
contains a Cas9 gene. After three days in cell culture, cells were counted with a
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hemocytometer, diluted, and dispensed in four 96-well dishes at a concentration of 0.5 cells
per well, to maximize the chance of single cell well cloning. After one week of culture, all
wells were visually analyzed and cells clusters were found in 90 wells out of a total of 384.
Only 67 out of 90 positive wells were propagated further since they showed a single cluster
of growing cells, whereas 23 wells showed two distinct cell clusters and were discarded
(non-clonal).

After several passages to amplify cell numbers, an aliquot of each clone was stored in liquid
nitrogen (in 90% FBS and 10% DMSO), while another aliquot was processed for PCRmediated RIOK3 allele analysis. Genomic DNA from each clonal population was extracted by
an overnight incubation at 50 °C in lysis buffer (10 mM Tris-HCl pH7.5, 10 mM EDTA, 10 mM
NaCl, 0.5% (w/v) sarkosyl, 1 mg/ml fresh Proteinase K) followed by phenol/chloroform
extraction and ethanol precipitation. Genomic DNAs were digested by BamHI restriction
enzyme to increase the screening efficiency during the PCR reactions. Each clonal genomic
DNA was submitted to two distinct PCR reactions with a pair of primers located either in
exons 3 and 4 or in exons 3 and 5 (exon3-F, CCAGTGACCTTATGCTG; exon4-R,
TATCGCTGTCTTCATAAGGA; exon5-R, AATAAAGCCCTTTTTAGGAGT). The oligonucleotide
primers were designed to have their 3' ends bind to the region targeted by the guide RNA
and, more precisely, to the nucleotides where most short deletions have been observed
(Jacobi et al., 2017). We thus expected that any change in the targeted region, even a small
one, would negatively affect the PCR reaction outcome. Only five clones out of 67 remained
negative for both PCR reactions, which was indicative that both alleles had been modified.
Sanger sequencing and interpretation of the results showed that three clones out of five
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exhibited deletions within both alleles, leading to frame-shift induced appearance of
premature stop codons in exons 3 and 4. These PTCs made the subsequent mRNAs good
candidates for nonsense mediated decay. Even if these mRNAs escaped NMD and were
translated, the severely truncated RIOK3 protein (predicted size 80–160 aa) would be
missing the kinase domain that is assumed to be essential for its function. The lack of
expression of any large RIOK3 protein species in the KO lines was confirmed by Western
blotting using concentrated extracts from the three RIOK3-KO 293 cell clones.

RT-qPCR
Total RNA was extracted using the PureLink RNA Mini Kit (Thermo Fisher Scientific) or
TRIzol (Thermo Fisher Scientific) and RNA was reverse transcribed using Superscript III
First-Strand Synthesis SuperMix (Thermo Fisher Scientific) or Maxima H Minus Reverse
Transcriptase (Thermo Fisher Scientific) with random hexamers according to the
manufacturer’s instructions. qPCR was performed using the Applied Biosystems Step One
Real-Time PCR System or the CFX Connect Real-Time PCR Detection System (Bio-Rad). RNA
levels were normalized to GAPDH. Fold change in expression was calculated using the ∆∆CT
method (Livak and Schmittgen, 2001). Primers used for qPCR are as follows: RIOK3 Exons
1/2

(F-GCCTTCATTCCCGAATGGATCTGGTAG,

RIOK3

Exons

7/8

(Qiagen

R-GCCAGCTGTTCACTCATTACATCAGCC),

Quantitect

Primer

Assay),

X2

variant

(F-

TGCCATCAAGAATGCAGAGA, R- TAACTGCCGCATCAAATGAA), GAPDH (Qiagen Quantitect
Primer

Assay),

interferon

beta

(F-

AAACTCATGAGCAGTCTGCA,

R-

AGGAGATCTTCAGTTTCGGAGG).
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cDNA Cloning
Total RNA was extracted using the PureLink RNA Mini Kit (Thermo Fisher Scientific) from
uninfected HEK293 cells and rLuc RVFV infected HEK293 cells 24 hpi. 600 ng of RNA was
reverse transcribed using Superscript III First-Strand Synthesis SuperMix (Thermo Fisher
Scientific) with random hexamers according to the manufacturer’s instructions. From the
random hexamer cDNA pool, full-length (mRNA) RIOK3 cDNA was amplified using RIOK3specific primers complementary to the sequences adjacent to start and stop codons of the
full-length RIOK3 ORF. Using this strategy, we examined only the fully processed full length
mRNAs/cDNAs and not potentially transient splicing intermediates. RIOK3 cDNAs was
cloned into the pDC316io expression plasmid using RIOK3-specific primers and transformed
into E. coli. Collections of several individual clones, corresponding to mock- or RVFV MP-12
infected cells, were prepared by minipreparation of plasmid DNA and analyzed by Sanger
sequencing.

Cycloheximide Assays
HEK293 cells were treated with 100 μg/mL cycloheximide and total RNA was harvested at
timepoints post-treatment. Total RNA was extracted using the PureLink RNA Mini Kit
(Thermo Fisher Scientific) and treated with RQ1 DNase (Promega). 600 ng of RNA was
reverse transcribed using Superscript III First-Strand Synthesis SuperMix (Thermo Fisher
Scientific) with random hexamers according to the manufacturer’s instructions. RIOK3
species present in the cDNA were amplified by PCR using primers spanning several exons
surrounding the alternatively spliced region (F- CCGGTTCCCACTCCTAAAAAGGGC, RCCAGCATGCCACAGCATGTTATACTCAC) and CloneAmp HiFi PCR Premix (Takara, Mountain
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View, USA). PCR products were run on a 1.8% agarose gel and stained with ethidium
bromide. Fluorescence imaging was performed using a Fujifilm LAS-3000 imager.

Statistical Analysis
Statistical analyses were performed with GraphPad Prism 8 using a two-tailed unpaired
Student’s t-test to assess significant differences between experimental treatments.
Experimental error bars represent the standard error of the mean (SEM) (see figure
legends). All qPCR data presented are representative of experiments including biological
triplicates and technical duplicates. All data including RIOK3 knockout cells are
representative of repeated experiments with at least two clonal cell lines.

Results
RIOK3 Is A Component of A Cellular Antiviral Pathway during RVFV MP-12 Infection.
RIOK3 expression can be either necessary for or detrimental to viral propagation, depending
on the virus. To assess the importance of RIOK3 during infection, HEK293 cells were first
transfected with control or RIOK3-targeting siRNAs and were infected 24 h later with RVFV
MP-12. MP-12 is a commonly used attenuated strain of RVFV that allows for viral work to be
completed under BSL2 containment conditions (Vialat et al., 1997). RIOK3 siRNA
knockdown decreased RIOK3 mRNA by approximately 80%, which indicated that the
transcription and the degradation of RIOK3 mRNA are relatively rapid (Figure 7A). At 24 hpi,
newly made RVFV MP-12 particles were collected from the supernatants of the infected cells
and the number of infectious particles was determined by plaque assay. Knockdown of
RIOK3 resulted in a 10-fold increase of the number of infectious MP-12 particles produced
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(Figure 7B). This result indicated that normal expression of the RIOK3 gene is important to
suppress the production of infectious particles.

To further analyze how the production of infectious particles could be affected by RIOK3
expression, we used a complementary reporter gene assay and mutant derivative of the MP12 virus called rLuc RVFV (Gommet et al., 2011) that harbors a Renilla luciferase open
reading frame in place of the gene for the viral nonstructural protein NSs. NSs is a major
virulence factor that plays several roles in RVFV pathogenesis and mitigates the host
antiviral response by interfering with host transcription, PKR activation and IFNB promoter
usage (Le May et al., 2008; Kalveram et al., 2013). HEK293 cells were first transfected with
control or RIOK3 siRNAs and infected 24 h later with rLuc RVFV. The siRNA-dependent
decrease in RIOK3 expression correlated with an increase of rLuc gene expression (Figure
7C). Since the rLuc gene is both virally encoded in the mutant virus, and its expression
depends on an efficient viral transcription by L and N viral products, the results in Figure 7C
suggest that RIOK3 decreases the expression of virally encoded luciferase in infected cells.
This model is further corroborated by the fact that overexpression of exogenous FLAGtagged RIOK3 followed by infection with rLuc RVFV yielded a decrease in virally encoded
Renilla luciferase protein production as measured by luciferase activity (Figure 7D). Taken
together, these results indicate that RIOK3 expression correlates with diminished viral
replication and protein expression, and thus functions in an antiviral capacity during RVFV
infection.
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Figure 7: RIOK3 plays an antiviral role during RVFV MP-12 infection. (A) siRNA knockdown of
RIOK3. HEK293 cells were transfected with RIOK3 (Qiagen nos. Hs_RIOK3_4 and Hs_RIOK3_8)
or control siRNAs. Total RNA was extracted and RIOK3 mRNA was quantified by RT-qPCR. (B)
Effect of RIOK3 knockdown on MP-12 titer. HEK293 cells were transfected with mock or RIOK3
siRNAs, then infected with RVFV strain MP-12. The viral titer in the supernatant at 24 hpi was
quantified by plaque assay. (C) Effect of RIOK3 knockdown on rLuc RVFV transcriptional
activity. HEK293 cells were transfected with siRNA targeted to RIOK3 or a negative control and
infected with rLuc RVFV. The Renilla luciferase activity was quantified at 24 hpi and indicated
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the level of RVFV transcriptional activity. (D) Effect of RIOK3 overexpression on rLuc RVFV
transcriptional activity. Cell lysates were prepared from HEK293 cells transfected with Nterminally FLAG tagged RIOK3 or mock transfected and protein levels were determined by
Western blotting. Transfected cells were infected with rLuc RVFV and the level of Renilla
luciferase activity was quantified at 24 hpi. In all panels, data are presented as mean +/− SEM
of duplicate (C) or triplicate (A, B, D) biological replicates. Student’s t-test: *** p < 0.001, ** p
< 0.01, * p < 0.05.

RIOK3 Is Involved in the Activation of Type I IFN Response.
To further investigate the role(s) and significance of RIOK3 in the antiviral response, a RIOK3
CRISPR knockout (KO) cell line was generated (see Materials and Methods). Sequence
analysis of genomic PCR amplicons of CRISPR targeted regions revealed frameshift
mutations and deletions in both chromosomal copies RIOK3 in several clones and IP-western
analysis confirmed the absence of RIOK3 in three different CRISPR KO cell clones (Figure
8A). As a functional screen, RIOK3 KO and normal cells were infected with MP-12 and the
titers of the newly synthetized viral particles released from the infected cells were analyzed
by plaque assay, as described for Figure 7B. Similar to the siRNAs-mediated knockdown of
RIOK3 expression, RVFV MP-12 replication in the infected RIOK3 KO cells led to a
reproducible increase of the viral titer when compared to normal cells (Figure 8B). It is
curious that knockdown and knockout of RIOK3 had differential effects on RVFV replication,
with knockdown causing better replication of RVFV than knockout. Whether this is because
the siRNA “primed” the innate immune response, whether RVFV replicates better with a
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small amount of RIOK3, or because of other possible mutations in the knockdown cells is
unclear and may be worth investigating further.

Previous studies suggested that RIOK3 is involved in the transmission of activation signals
from RNA-specific pattern recognition receptors to the promoters of interferon-specific
genes. To test whether RIOK3 was involved in IFN expression during RVFV infection, we
performed RT-qPCR targeting IFNB mRNA in RVFV-infected HEK293 cells and RIOK3 KO
cells. We found that IFNB expression was significantly diminished in the RIOK3 KO cell lines
(Figure 8C). Next, we wanted to determine which upstream factors this IFNB expression
decrease could be attributed to. To test this, we transfected poly (I:C)- or 3p-hpRNA into
RIOK3 KO cells and compared IFNB expression to normal stimulated HEK293 cells. Poly (I:C)
is a double stranded RNA analog that is known to elicit cellular responses similar to those
that occur during certain RNA virus infections by activating both the MDA5 and RIG-I
pathways (Palchetti et al., 2015), and 3p-hpRNA is a specific RIG-I agonist comprised of an
87-nt hairpin (Nelson et al., 2020). We found that the RIOK3 KO cells had a significant
decrease in the amount of total interferon beta (IFNB) mRNA when stimulated in two
independently isolated clones of the RIOK3 KO, representative data are presented in Figure
8D,E. We then complemented RIOK3 KO cells with an expression plasmid encoding fulllength RIOK3 protein to assess whether restoring expression of RIOK3 could rescue IFNB
expression. We treated plasmid-transfected cells with poly (I:C) and tested IFNB via qRTPCR,
and found that IFNB expression was increased when RIOK3 was added back to cells via
plasmid (Figure 8F). These data indicate that RIOK3 acts downstream of RIG-I activation and
upstream of IFNB expression.
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In parallel, an IFNB reporter plasmid was transfected in either HEK293 or RIOK3 KO cells to
measure the level of IFNB promoter activation (Figure 8G). Following transfection, the cells
were stimulated by either poly (I:C) transfection or MP-12 infection and the level of IFNB
promoter activity was measured by luciferase assay. The RIOK3 KO cell lines exhibited
significantly decreased activation of the reporter plasmid following both types of
stimulation, indicating that RIOK3 is involved in the signal transduction during IFNB
promoter activation at a step either concomitant with or preceding IRF3 translocation into
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Figure 8: RIOK3 is involved in the signal transduction of the type I IFN response. (A) HEK293
cells and three RIOK3 KO cell lines were screened for RIOK3 protein expression by IP-Western
blot. (B) HEK293 cells and RIOK3 KO cells were infected with MP-12 (MOI 1.0). The viral titer
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in the 24 hpi supernatant was quantified by plaque assay. (C,D) RT-qPCR targeting IFNB was
performed on RNA from HEK293 cells and RIOK3 KO cells infected with MP12 (C) or treated
with poly (I:C) (D) or 3p-hpRNA (E) for 18 hours. (F) RT-qPCR targeting IFNB was performed
on RIOK3 KO cells transfected with a GFP (mock) or RIOK3 expression plasmid and treated with
poly (I:C) 18 hours later. (G) Effect of RIOK3 KO on IFNB promoter activation. HEK293 cells and
RIOK3 KO cells were co-transfected with pGL3-IFNB firefly reporter and phRL-CMV renilla
control. Cells were stimulated with poly (I:C) or infected with MP-12 and the dual luciferase
signals were measured after 18 or 48 h, respectively. In panels B–F, data are presented as mean
+/− SEM from three biological replicates. Western blots in panels A is representative of
duplicate experiments. Student’s t-test: ** p < 0.01, * p < 0.05.

RNA Virus Infection and Poly (I:C) Trigger RIOK3 Alternative Splicing.
Our prior work showed that RIOK3 alternative splicing increased during RVFV MP-12
infection. The importance of studying the population of RIOK3 splicing isoforms is
underscored by the fact that translation of X1 or X2 splice variants described below would
produce truncated RIOK3 protein isoforms missing most of the structural kinase domain.
There are several mRNA isoforms described in GenBank; in addition to the canonically
spliced RIOK3 transcript (NM_003831), which we call “full-length” here to indicate that it
incorporates the largest exon 8 (see Figure 11) and does not lead to incorporation of
premature termination codons, two other near full-length splice variants are documented:
XM_011526242 (X1 variant), XM_011526243 (X2 variant), which affect splicing in exons 7
and 8, respectively. The X1 transcript corresponds to full-length RIOK3 but with exon 7
skipped altogether during splicing. The X2 variant, whose abundance increased during MP73

12 infection, uses an alternative 5’ splice site in exon 8. The X1 event also appeared as a
differentially spliced transcript occurring during infection, but it was below threshold
parameters so it was not considered a statistically significant event.

To capture the different RIOK3 transcripts present during rLuc RVFV infection and confirm
the presence of X2 and X1 variants, cDNAs were produced and sequenced from the RNA
lysates of both mock- and rLuc RVFV-infected cells. We amplified cDNA with primers in the
first and last exons of RIOK3 to enrich for only full-length mRNAs and not partially processed
fragments and cloned them into a plasmid. Individual clones were purified and sequenced.
The population of large RIOK3 transcripts in uninfected cells largely consisted of full-length
RIOK3 mRNA (NM_003831), with a small proportion of the RIOK3 X2 variant (Figure 9A).
However, the cDNA clones from infected cells correspond to mostly alternatively spliced
species, with only a small proportion of full-length RIOK3 (Figure 9B). An X1/X2 hybrid
variant, the product of both exon 7 skipping and exon 8 truncation, was also detected in
infected cells. Since we detected a large increase of the RIOK3 X2 variant when sequencing
fully processed mRNA-length RIOK3 isoforms, RT-qPCR with primers flanking the exon 8
was used to compare the levels of X2 alternative splicing events in cells infected with either
MP-12 or rLuc RVFV particles at a multiplicity of infection (MOI) of 1 (MOIs were defined by
the percentage of cells expressing the viral nucleocapsid protein in the first 24 h post
infection as measured by flow cytometry). Relative to mock infected cells, the X2 variant
increased by ~22 fold by 24 hpi in cells infected with MP-12 (Figure 9C). In rLuc RVFV
infected cells, the X2 splicing variant increased by ~38 fold by 24hpi (Figure 9C). The greater
increase in RIOK3 X2 variant alternative splicing during rLuc RVFV infection is probably
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related to the lack of the major virulence factor NSs that effects host transcriptional shutoff.
Thus, the rLuc infected cells produce more RIOK3 transcripts early in infection, and
alternative splicing ensues, promoted either by cellular regulatory mechanisms or by the
virus to blunt the innate immune response. The fact that X2 alternative splicing occurs with
the NSs-defective rLuc virus indicates that NSs is not the root cause of this alternative
splicing.

To determine whether RVFV MP-12 infection presents a unique circumstance under which
RIOK3 alternative splicing is activated, other viral or viral-like stimuli were tested for their
ability to prompt an increase in RIOK3 X2 variant alternative splicing. Transfection of
HEK293 cells with poly (I:C) increased the fraction of RIOK3 X2 variant RNA (Figure 10A).
Additionally, transfection of 3p-hpRNA, a short double-stranded RNA that specifically
stimulates RIG-I (and not MDA5), caused an increase in RIOK3 X2 mRNA (Figure 10D).
Similarly, infection of HEK293 cells with Tacaribe virus (TCRV), a New World Arenavirus
with single-stranded negative sense RNA genome, increased the fraction of RIOK3 X2 variant
RNA (Figure 10B). In contrast, infection with Adenovirus, a double-stranded DNA virus, did
not promote RIOK3 X2 variant alternative splicing (Figure 10C). Similar trends were found
in preliminary studies with Sindbis virus (EgAr339), a positive sense single-stranded RNA
alphavirus that also caused RIOK3 alternative splicing, and with human cytomegalovirus
HCMV (strain TR), a large double-stranded DNA herpesvirus that did not trigger RIOK3
alternative splicing (data not shown). These results suggest a relationship exists between
RIOK3 alternative splicing and activation of the viral RNA sensors of the interferon response
pathways, particularly RIG-I, during infection with the RNA viruses and treatments tested.
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isoforms at exons 8 and 9, and not necessarily in full length poly-adenylylated mRNAs, which
were characterized in panels A and B. Data in panel C is presented as mean +/− SEM from
triplicate experiments. (D) Schematic of the different splicing patterns observed. X2 employs a
cryptic splice donor site within exon 8, resulting in a shortened exon 8 and a new stop codon in
exon 9. X1 skips exon 7 entirely. Some transcripts contained both X1 and X2 type alternative
splicing.

Canonical RIOK3 mRNA Splicing Is Vital for IFN Activation.
We next tested whether the RIOK3 X2 splicing event had an effect on IFNB production. We
used a morpholino oligonucleotide (MO) (Gene Tools, LLC, Philomath, OR, USA) to occlude
the RIOK3 FL splice site while treating cells with poly (I:C) or 3p-hpRNA. Morpholino oligos
are highly stable nucleic acid mimics that can be used to occlude splice junctions in premRNAs without eliciting degradation of the RNA by cellular RNaseH activity (Summerton,
2007; Regis et al., 2013). We hypothesized that transfection of the appropriate MO would
force cells to express more X2 RIOK3 mRNA isoform without activating the RLR pathways.
We further hypothesized that increased expression of the X2 isoform would result in
decreased expression of full-length RIOK3 protein, affecting downstream IFNB mRNA
expression. First, to confirm that X2 expression is increased upon MO treatment, we
transfected cells with increasing concentrations of MO and performed RT-PCR followed by
gel electrophoresis (Figure 10E). The gel was visualized on a Fuji LAS-1000 imager and the
band intensities were quantified using ImageJ. Even at the lowest concentration (2 μM) of
transfected MO, we observed a marked increase in X2 isoform mRNA expression that
accompanied decreased abundance of canonically spliced RIOK3 mRNA, from 24%
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alternatively spliced isoforms in mock-transfected cells to 45% at 2 μM MO. This percentage
increased with increasing MO dosage up to 60% alternatively spliced at 10 μM (Figure 10E).
Next, we used qRT-qPCR to quantify IFNB mRNA expression in poly I:C stimulated cells that
were pre-treated with the MO. We observed that IFNB mRNA expression was reduced as a
result of the MO treatment (Figure 10F). This indicates that the RIOK3 alternative splicing
event can mitigate the cellular innate immune response, which may be important to limit an
excessive or prolonged inflammatory/antiviral response.
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cells were transfected with poly (I:C) (A), or infected with either the RNA virus Tacaribe (TCRV)
(B), or the DNA virus adenovirus (ADV) (C). Total RNA was harvested 24 h post transcription
or infection and RT-qPCR was used to quantify the relative fraction of X2 variant and full-length
canonically spliced RIOK3 species. Data are presented as mean +/− SEM based on duplicate
experiments. Student’s t-test: * p < 0.05. (D) HEK293 cells were transfected with 1 μg/mL 3phpRNA. RT-PCR targeted the region spanning RIOK3 exons 5–10, followed by agarose gel
electrophoresis. Splicing isoforms are indicated. (E) Morpholino oligonucleotide targeting the
canonical exon 8 splice donor site of RIOK3 pre-mRNA was transfected into HEK293 cells in
increasing concentration (2–10 μM) for 18 h. RNA was processed via RT-PCR and run on
agarose gel. (F) RT-qPCR was performed to measure the expression of IFNB mRNA after 18 h
MO (8 μM) transfection and subsequent stimulation by either poly (I:C) or 3p-hpRNA. Data is
presented as mean +/− SEM from triplicate experiments. Student’s t-test: ** p < 0.01, * p < 0.05.

RIOK3 X2 Variant RNA Transcripts Are Substrates for Nonsense-Mediated Decay.
Although no structural data currently exist for RIOK3, sequence homology based on the
known RIOK1 functional domains allows for prediction of two domains: an N-terminal
domain that is divergent from other RIO family proteins and whose function is largely
undetermined, and a highly conserved C-terminal RIO kinase domain (Baumas et al., 2012).
In the case of the RIOK3 X2-variant, the alternative splicing results in a frameshift that
introduces a downstream premature termination codon (PTC) in exon 9. This leaves a much
smaller open reading frame that encodes a truncated RIOK3 protein lacking most of the
kinase domain (Figure 11A). Furthermore, the introduction of a PTC renders these
transcripts canonical candidates for nonsense-mediated decay (NMD), since a termination
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codon greater than 50 nucleotides upstream of the final exon junction is considered to be
premature and triggers NMD in mammalian cells (Hug et al., 2015). To test whether RIOK3
X2 variant RNA transcripts are targeted by the NMD machinery, cells were treated with
cycloheximide, a translation inhibitor and commonly used probe of NMD activity
(Pereverzev et al., 2015). Cycloheximide is an effective NMD inhibitor because NMD relies
on functional ribosomes and active translation. RNA was isolated from treated and untreated
cells, reverse transcribed to cDNA and PCR amplified with primers flanking the alternatively
spliced exons. Two bands appeared over time in cycloheximide treated cells that
corresponded to the X2 and X1/X2 hybrid variants (Figure 11B). The identity of these bands
was verified by sequence analysis. These results demonstrate that the alternatively spliced
X2 variant RIOK3 transcript is a NMD substrate.

In our system, despite the documented abundance of the X2 variant RIOK3 transcript, we
could not detect an endogenously expressed truncated protein corresponding to its
translation using commercially available antibodies, suggesting that either the mRNA is
rapidly degraded or that the truncated protein is poorly detectable or unstable in cells. We
cloned both full-length and X2 variant RIOK3 cDNAs into a mammalian expression construct
with a FLAG tag on their N-terminus. Transfection of stoichiometrically equivalent amounts
of either full-length or X2 variant FLAG-tagged constructs into HEK293 cells showed
detectable amounts for both FLAG-tagged proteins (Figure 11C). However, the weaker band
intensity of the X2 variant protein suggests either that the protein expression from the X2
variant RIOK3 construct was much less robust than the one from the full-length RIOK3
construct or that the shorter protein is turned over rapidly. In summary, it is likely that the
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X2-spliced mRNA variant product of RIOK3 is targeted for decay by the NMD machinery, and
translation of any X2 variant mRNA that survives NMD degradation may produce an unstable
and catalytically inactive truncated version of the full-length RIOK3 kinase protein owing to
its truncated C-terminal region.
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Figure 11: RIOK3 X2 variant mRNA encodes a truncated protein product and is targeted by
nonsense-mediated decay (NMD). (A) Schematic of the normal and X2 variant alternative
splicing on the precursor RIOK3 RNA transcript together with a representation of the fulllength and X2 variant RIOK3 protein isoforms. (B) Alternatively spliced RIOK3 mRNA is
efficiently degraded by nonsense mediated decay. HEK293 cells were mock treated or treated
with cycloheximide (CHX) for the times indicated. Total RNA was harvested and subjected to
RT-PCR using primers flanking the spliced exons. PCR products were run on agarose and
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stained using ethidium bromide. As CHX inhibits NMD, X2 and X1/X2 products are preserved
with treatment. Actin B was used as a control. (C) Expression of RIOK3 full-length and X2
variant proteins from transfected expression plasmids. RIOK3 full-length and X2 constructs
were transfected into HEK293 cells and expression was analyzed by Western blot. The presence
of the same FLAG tag at the N-terminus of both proteins allowed us to compare their expression
efficiencies.

Discussion
Upon infection by any virus, mammalian cells take immediate steps to limit viral success, and
concurrently the virus initiates measures to limit the cell’s antiviral responses. In prior work,
we discovered that soon after infection with RVFV MP-12, transcription of the kinase, RIOK3
is upregulated, and curiously, the splicing pattern of the RIOK3 mRNA changes rapidly as
well. In the work presented here, we demonstrate that RIOK3 expressed in its canonically
spliced form is important for interferon expression, an important antiviral response. We
further demonstrate that expression of the alternatively spliced isoform of RIOK3 does not
contribute to the robust interferon response. We propose that the alternative splicing of
RIOK3 moderates the IFN response, and that this alternative splicing is programmed by the
cell to prevent an excessively prolonged interferon response, or that this mechanism is
hijacked by the virus early in infection to blunt the antiviral response to infection, or both.

Regulation of alternative splicing is a complex process that is not based on a clearly
understood set of rules. Rather, it is a layered regulatory phenomenon in which splice site
selection is determined by a variety of cis- and trans-factors acting in concert (Fu and Ares,
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2014). The picture becomes even more complex during viral infection, where the hostpathogen dynamic strongly influences cellular metabolism. Alternative splicing patterns
during viral invasion are often a combination of a programmed host response to counteract
the infection as well as viral efforts to interfere with the host splicing machinery (De Maio et
al., 2016; Rivera-Serrano et al., 2017).

Our prior transcriptome profiling study of RVFV MP-12-infected cells indicated that RIOK3,
a host factor recently characterized as an important player in the host antiviral response, is
alternatively spliced during infection. This splicing event was particularly intriguing since
work performed by Feng and colleagues illustrated that knockdown of RIOK3 during
infection with MHV-68 herpesvirus and influenza A virus (IAV, strain A/WSN/33) in
HEK293T cells led to an increase in viral titer of 5-fold and 15-fold, respectively (Feng et al.,
2014). They further showed that RIOK3 is required for induction of type I IFN after challenge
with Sendai Virus (SeV) or poly(I:C). Their model suggests that RIOK3 mediates the
interaction between IRF3 and TBK1, which is required for IRF3 dimerization, subsequent
translocation into the nucleus and production of type I IFN and transcription factors NF-κB
and AP-1 (Yoneyama et al., 2015). In contrast, work by Takashima and colleagues suggested
that RIOK3 phosphorylates the pattern recognition receptor MDA5 at Ser-828, which
hinders MDA5 activation in uninfected and virus-infected HEK293 cells, thereby attenuating
the antiviral response (Takashima et al., 2015). Specifically, they showed that RIOK3
knockout enhanced the type I IFN response after measles virus (MV) infection. MDA5
activation is triggered by RNA elements from certain viruses, like measles, polio and
encephalomyocarditis viruses (Takaki et al., 2011; Abe et al., 2012; Runge et al., 2014), while
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RIG-I is the PRR that activates the IFNB pathway during infection by a distinct subset of
negative sense RNA viruses, including IAV, SeV and RVFV (Kato et al., 2006; Habjan et al.,
2008; Loo et al., 2008; Yoneyama et al., 2015). Furthermore, Gokhale and colleagues
reported that RIOK3 is required for productive infection of Dengue virus and Zika virus, but
is inhibitory towards hepatitis C virus (Gokhale et al., 2020). Differential responses to
particular types of viruses could explain the apparent discrepancy between these studies but
they nevertheless suggest dual functions for RIOK3 within the same or parallel pathways
culminating in production of interferon.

In the present study, we show that RIOK3 acts in an antiviral capacity during RVFV MP-12
infection and plays a critical role in activation of IFN signaling. Knockdown or knockout of
endogenous RIOK3 led to enhanced viral replication and decreased activation of type I IFN
signaling, and re-addition of RIOK3 to knockout cells rescued IFN signaling. The increase in
viral replication after knockdown/knockout is notable since cellular mutations that diminish
cellular vitality can also diminish virus propagation. Several other genes whose disruption is
linked to higher virulence or disruption of innate immune pathways have been identified in
previous studies (e.g., (Ikegami et al., 2009; Hise et al., 2015)). Our observation that
overexpression of full length RIOK3 makes wild type cells modestly more resistant to
infection is consistent with its role in a pathway(s) in which both the abundance and the
cellular activation of the components of the pathway are essential to observe the response.
Thus, overexpression of RIOK3 would be expected to aid in the cellular antiviral response,
but other components of this pathway that are not overexpressed would become ratelimiting.
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This report shows that RIOK3 is a critical component of the IFN signaling pathway triggered
by RVFV MP-12 infection and by treatment with poly (I:C) and 3p-hpRNA. As the effect of
knocking out RIOK3 is very pronounced when treating cells with 3p-hpRNA, we propose that
RIOK3 is component of the RIG-I pathway.

The marked change in the splicing pattern of RIOK3 mRNA upon infection or treatment with
poly (I:C) or 3p-hpRNA is intriguing. Interestingly, the alternatively spliced X2 variant RIOK3
transcript was represented in spliced EST samples collected from both humans and mice
(see Table 4), suggesting a conserved functional role outside of the context of infection. Here,
we show that altering the abundance of RIOK3 isoforms to favor X2 through MO treatment
caused a significant decrease in IFNB mRNA expression, implying that this alternative
splicing event represents a mechanism to control the IFNB response. It is curious that innate
immune activators would simultaneously cause a splicing event that deactivates innate
immunity. A plausible explanation is that the AS occurs to prevent excessive innate immune
response, which would be detrimental to the cell and surrounding tissue in vivo. A study
closely measuring the temporal regulation of splicing and immune activation will be
important to distinguish these seemingly disparate effects.

Table 4: Spliced Expressed Sequence Tags (ESTs) that contain RIOK3 X1 and X2 variant splice
junctions.
EST

GENOME

TISSUE
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BQ311197

X1

human

breast

BF134913

X1

mouse

mammary metastatic tumor tissue

BI156659

X1

mouse

gross tumor tissue

BE308968

X1

mouse

gross tumor tissue

DC420826

X2

human

uterus

CA317387

X2

mouse

fetal brain tissue

CA980650

X2

mouse

pooled embryonic limb

DB184699

X1/X2 human

liver tumor

How does AS regulate RIOK3 function? The two non-mutually exclusive possibilities are that
AS simply reduces the intracellular level of functional RIOK3 protein, or that the protein
expressed from the AS transcript has inhibitory properties itself. The putative protein
product of RIOK3 X2 variant is truncated at the C-terminal region, which would render the
kinase domain non-functional. We were unable to observe an endogenous truncated “X2”
protein by western analysis, but this may be because of low abundance and/or lack of
reactivity to our antibodies. Our work suggests that the X2 protein isoform is unstable and
that the PTC in exon 9 renders RIOK3 X2 variant mRNA a target of the NMD machinery.
However, even as a short-lived protein the putative X2 protein isoform could have a role in
slowing IFNB signaling, e.g., by competitively interfering with interprotein interactions that
normally constitute essential parts of the IFN signaling pathway(s). Either possibility
suggests that RIOK3 expression could be regulated qualitatively and/or quantitatively at the
level of alternative splicing in order to fine-tune the host response to infection (see Figure
12).
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Figure 12: Relationship between RIOK3 splicing products, RVFV MP-12 infection, and innate
immune activation. The human RIOK3 gene is represented at the top of the panel with its 13
exons. The normal RIOK3 protein with a complete kinase domain is called full-length and
produced by translation of a canonically spliced transcript encompassing the 13 exons (left side
of figure). Alternative 5' splice donor usage shortens exon 8 and results in the X2 variant mRNA.
Translation of the X2 mRNA would produce a truncated RIOK3 missing most of the kinase
domain (right side of figure). Notably, the X2 RNA contains an exonic premature termination
codon making it a canonical substrate for nonsense-mediated decay and rapid degradation.
The effects on RIOK3 gene expression during MP-12 infection (blue arrows) compared to
uninfected cells (orange arrows) are shown. The magnitude of the effect is represented by the
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thickness of each arrow. It is not known if the X2 variant RIOK3 protein is expressed or stable,
or if it possesses any function. By contrast, the full-length RIOK3 protein has been suggested to
be involved in several diverse cell functions and pathways (see text), thus the relative expression
levels of full length and X2 variants of RIOK3 can have strong effects on cellular functions
including the antiviral response.

Regulation at the level of alternative splicing is not uncommon among innate immune
effector proteins (Karpova et al., 2001; Janssens et al., 2003; Rosenstiel et al., 2006; Deng et
al., 2008; Lad et al., 2008; Koop et al., 2011). For example, alternative splice variants of the
inhibitor of κB kinase ε (IKKε) are translated and function as dominant negative inhibitors
of IRF3 or NF-κB activation (Koop et al., 2011). Similarly, TBK1 is alternatively spliced during
SeV infection to produce an alternatively spliced isoform that shuts down virus-induced
IFNB production (Deng et al., 2008). Additionally, many transcripts originally thought to
encode truncated proteins have since been characterized as NMD targets (Lareau et al.,
2007). It is estimated that most human genes are alternatively spliced and about one-third
of alternative transcripts contain PTCs, rendering them potential NMD targets (Lewis et al.,
2003; Wang et al., 2008). NMD is commonly recognized as a mechanism to degrade
misspliced or aberrant transcripts in order to protect the cell from deleterious protein
isoforms. NMD is also involved in regulation of gene expression by coupling alternative
splicing with nonsense-mediated decay (Lareau et al., 2007).

In conclusion, we show that the transcript encoding RIOK3, an incompletely understood
immune regulatory protein, can be rendered nonfunctional by an alternative splicing event
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that is triggered by viral infection or other innate immune stimuli. Our data suggest that
expression of the alternatively spliced isoform of RIOK3 may be directly antagonistic to the
downstream immune responses, and may be a mechanism by which cells prevent excessive
immune response. Future studies will aim to identify which cis- and trans- splicing factors
are involved in the alternative 5’ splice site selection event that leads to RIOK3 X2 variant
production, and whether the truncated X2 isoform is functional. Since roles for RIOK3 have
also been postulated in cancer and the tumor microenvironment (Singleton et al., 2015;
Zhang et al., 2018b), the regulation of RIOK3 splicing represents a potentially compelling
area of study in the realm of host–virus interactions as well as other areas of immune biology
and medicine.
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Chapter 4: Tra2beta-dependent regulation of RIO Kinase 3
splicing during Rift Valley fever virus infection underscores the
links between alternative splicing and innate antiviral immunity
Luke Adam White, Thomas C. Bisom, Hunter L. Grimes, Miyuki Hayashi, Jean-Marc Lanchy,
and J. Stephen Lodmell

This chapter is a modified version of a manuscript that is published in Frontiers in Cellular
and Infection Microbiology (White LA, Bisom TC, Grimes HL, Hayashi M, Lanchy JM, Lodmell
JS. Tra2beta-Dependent Regulation of RIO Kinase 3 Splicing During Rift Valley Fever Virus
Infection Underscores the Links Between Alternative Splicing and Innate Antiviral
Immunity. Front Cell Infect Microbiol. 2022;11:799024. PMCID: PMCPMC8807687). Luke
White carried out most of the experiments, wrote the entirety of the original draft and
constructed all of the figures.
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Abstract
Rift Valley fever virus (RVFV) is an emerging pathogen that has potential to cause severe
disease in humans and domestic livestock. Propagation of RVFV strain MP-12 is negatively
impacted by the actions of RIOK3, a protein involved in the cellular immune response to viral
infection. During RVFV infection, RIOK3 mRNA is alternatively spliced to produce an isoform
that correlates with the inhibition of interferon b signaling. Here, we identify splicing factor
TRA2-b (also known as TRA2beta and hTRA2-b) as a key regulator governing the relative
abundance of RIOK3 splicing isoforms. Using RT-PCR and minigenes, we determined that
TRA2-b interaction with RIOK3 pre-mRNA was necessary for constitutive splicing of RIOK3
mRNA, and conversely, lack of TRA2-b engagement led to increased alternative splicing.
Expression of TRA2-b was found to be necessary for RIOK3’s antiviral effect against RVFV.
Intriguingly, TRA2-b mRNA is also alternatively spliced during RVFV infection, leading to a
decrease in cellular TRA2-b protein levels. These results suggest that splicing modulation
serves as an immune evasion strategy by RVFV and/or is a cellular mechanism to prevent
excessive immune response. Furthermore, the results suggest that TRA2-b can act as a key
regulator of additional steps of the innate immune response to viral infection.
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Introduction
Rift Valley fever virus (RVFV) is a mosquito-borne bunyavirus (Order Bunyavirales; Family
Phenuiviridae)(Adams et al., 2017) that is endemic to Africa and the Arabian Peninsula and
causes disease in livestock and humans. In livestock herds, RVFV causes abortive
pregnancies and severe illness in young animals, while in humans it can cause a variety of
symptoms, from mild flu-like symptoms to liver damage, blindness, hemorrhagic fever, and
death (Ikegami and Makino, 2011). There is also evidence that RVFV increases the
probability of miscarriage in infected women (Baudin et al., 2016). Its mosquito vectors,
species in the Aedes and Culex genera, are predicted to expand their range in response to
climate change (Samy et al., 2016; Ryan et al., 2019; Iwamura et al., 2020), making RVFV a
potential threat beyond Africa and the Arabian Peninsula. Because of its potential for severe
illness and spread, RVFV is listed as a Category A overlap select agent by the CDC/USDA.
There is currently no licensed human vaccine or proven drug treatment for RVFV, and a
deeper understanding of its replication and interaction with the host will be important for
developing strategies to combat RVFV disease.

The innate immune response against RNA virus infections, including RVFV, is activated
through RNA-detecting pattern-recognition receptors in mammalian cells such as RIG-I and
MDA5 and culminates in the activation of type-I interferon (IFN) and other cytokine
production (Kato et al., 2006). In reports from other laboratories as well as recent work in
our group, the relatively understudied Rio kinase 3 (RIOK3) has been described as a key, yet
enigmatic, member of the antiviral response pathway(s). In our system (Havranek et al.,
2021) and in the reports of Feng, et al. (Feng et al., 2014) and Willemsen, et al. (Willemsen
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et al., 2017), RIOK3 was shown to be involved in activation of the innate immune response
somewhere downstream of RIG-I. Curiously, in other systems RIOK3 has also been
implicated in deactivation of MDA5 and RIG-I (Takashima et al., 2015; Shen et al., 2021),
ascribing RIOK3 a role in muting the innate immune response. Additionally, different viruses
have distinct responses to RIOK3 depletion, with Rift Valley fever virus, hepatitis C virus, and
influenza A virus replicating faster in the absence of RIOK3 (Willemsen et al., 2017; Gokhale
et al., 2020; Havranek et al., 2021), and Zika virus, Dengue virus, and measles virus
replicating slower (Takashima et al., 2015; Gokhale and Horner, 2017). Thus, RIOK3 may act
in dual roles, both as an effector and an inhibitor of innate immune responses to viral
infection, depending on the cell type, virus type, and the immune pathway that has been
activated.

Transcriptomics studies have identified widespread changes in the gene expression and
alternative splicing of host genes during RNA virus infection (Boudreault et al., 2016; De
Maio et al., 2016; Hu et al., 2017a; Gokhale et al., 2021). Recently we observed that many
mRNAs were alternatively spliced upon infection with RVFV, among them RIOK3 (Havranek
et al., 2019). Alternative splicing, which has been observed for virtually every gene in
vertebrates, allows expression of a diverse range of proteins from a given gene (Leff et al.,
1986; Black, 2003; Manning and Cooper, 2017). Because potential splice sites are abundant
in mRNA, splice site selection is largely controlled by the carefully regulated expression of
splicing factors, which bind to specific regions of pre-mRNA and enhance or suppress
potential splice donor or acceptor sites en route to production of the mature mRNA (Long
and Caceres, 2008; Jangi and Sharp, 2014; Leclair et al., 2020). Identifying splicing factors
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and the RNA motifs to which they bind is an essential step in understanding how gene
expression is controlled in different conditions, including in response to viral infection.

RIOK3 mRNA is expressed as four major splice isoforms evidenced by RNAseq (Havranek et
al., 2019), which we call full-length (FL), X2, X1, and X1/X2 hybrid (Figure 13A). FL contains
the entire open reading frame including 13 complete exons for the full-length protein, while
X2 utilizes an alternative splice site in exon 8, resulting in a premature termination codon
(PTC) in exon 9. X1 excludes exon 7, resulting in a PTC in exon 8. The X1/X2 hybrid has the
X2 alternative splice site and a skipped exon 7. The most abundant RIOK3 splice isoform in
unstimulated HEK293 cells in culture is FL, while in infected cells X2 predominates. If
translated, X2 would lack a large portion of its putative kinase domain and would thus likely
be inactive as a kinase. Recently, we also found that constitutive RIOK3 splicing is required
for the activation of innate immunity, indicating that the splicing of RIOK3 may be an
essential step for regulation of its activity (Havranek et al., 2021).
In this work, we demonstrate that RIOK3 constitutive versus alternative splicing is
controlled by the splicing factor TRA2-b, and that RIOK3 is alternatively spliced to an
alternative isoform in response to RVFV infection in multiple cell types. We also show that
RIOK3 alternative splicing occurs shortly after the innate immune response is mobilized to
produce interferon. Additionally, we describe that TRA2-b itself is alternatively spliced
during RIG-I activation, suggesting that differential expression and processing of this splicing
factor may be crucially important to innate immune activation and/or modulation.
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Materials and Methods
Viruses, Cell Culture, and Infections
The MP-12 vaccine strain of RVFV was kindly provided by Brian Gowen (Utah State
University, Logan, UT, USA). Manipulations of the viruses used in this study are compliant
with both the Institutional Biosafety Committee at the University of Montana, Missoula, and
NIH requirements in regard to their handling under BSL2 containment conditions.
All cells were incubated at 37°C and 5% CO2. HEK293 (BEI Resources), HeLa (BEI Resources),
HFF (provided by Brent Ryckman, University of Montana, Missoula, MT, USA), and Vero (BEI
Resources) cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented
with 10% fetal bovine serum (FBS) and penicillin/streptomycin (P/S). HepG2 (provided by
Brooke Martin, University of Montana, Missoula, MT, USA), HC-04 (BEI Resources) , and SHSY5Y (provided by Stefan Stamm, University of Kentucky, Lexington, KY, USA) cells were
cultured in a 1:1 mixture of DMEM and F12 media, supplemented with 10% FBS and P/S. For
experiments using RVFV MP-12, cells were grown to 80-90% confluency, washed with PBS,
and overlaid with virus at multiplicity of infection (MOI) of 1. Cells were incubated with virus
for one hour, then media was replaced with growth media supplemented with 2% FBS and
P/S.

TCID50 experiments were carried out as previously described (Smith et al., 2019).

Plasmids and Cloning
The TRA2-b overexpression vector and pSpliceExpress minigene were gifts from Stefan
Stamm (University of Kentucky, Lexington, KY, USA). The RIOK3 minigene was constructed
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by amplifying the RIOK3 ORF from whole genomes extracted from HEK293 cells and
inserting it into pSpliceExpress. Mutant minigenes were generated by overlap extension
PCR. All clones were verified by sequencing.

Reverse Transcription, PCR, and qPCR
Total RNA was extracted using TRIzol (Thermo Fisher Scientific) and RNA was reverse
transcribed using Maxima H Minus Reverse Transcriptase (Thermo Fisher Scientific) with
random hexamers according to the manufacturer’s instructions. Standard PCR was carried
out using Phusion Flash Hi-Fidelity PCR Master Mix (Thermo Fisher Scientific). Products
were run on a 1% agarose gel and visualized using a Molecular Imager Gel Doc XR+
instrument (Bio-Rad). qPCR was performed using the CFX Connect Real-Time PCR Detection
System (Bio-Rad). RNA levels were normalized to GAPDH. Relative fold change in expression
was calculated using the ∆∆CT method (Livak and Schmittgen, 2001).

See Table 5 for primers and oligos used in this study.

Table 5: List of all primers and morpholino oligos used in this study.
Name

Sequence (5' to 3')

F_RIOK3_Endogenous

CCGGTTCCCACTCCTAAAAAGGGC

R_RIOK3_Endogenous

CCAGCATGCCACAGCATGTTATACTCAC

F_TRA2B

AGGAAGGTGCAAGAGGTTGG

R_TRA2B

TCCGTGAGCACTTCCACTTC
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F_RIOK3_Minigene

GACCCACAAGCATGGAGGATGA

R_RIOK3_Minigene

CCAGTTGTGCCAATGAAGAGTTTGA

F_IFNB

AAACTCATGAGCAGTCTGCA

R_IFNB

AGGAGATCTTCAGTTTCGGAGG

F_GAPDH

GTCTCCTCTGACTTCAACAGCG

R_GAPDH

ACCACCCTGTTGCTGTAGCCAA

RIOK3_FL_qPCR_F

GTCTGTTGTCTTTCATGCATATGGAGG

RIOK3_FL_qPCR_R

TGCCCACATGCGGATCTT

RIOK3_Exon1_F

GCCTTCATTCCCGAATGGATCTGGTAG

RIOK3_Exon2_R

GCCAGCTGTTCACTCATTACATCAGCC

RIOK3_X2_qPCR_F

TGCCATCAAGAATGCAGAGA

RIOK3_X2_qPCR_R

TAACTGCCGCATCAAATGAA

TRA2B_Morpholino

ACTTCTTTACCCTGTATATATTTTCCTCTA

Western Blotting
Cells were collected and lysed in radioimmunoprecipitation assay (RIPA) buffer with
protease inhibitors (10mM Tris-HCl pH 8.0, 140mM NaCl, 1mM EDTA, 0.5mM EGTA, 1%
Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS). Lysates were clarified and
subsequently separated by SDS-PAGE on 10% polyacrylamide and wet transferred to PVDF.
The membrane was blocked with 5% milk solution in Tris-buffered saline Tween 20 (TBST)
at room temperature, and primary antibody was added at a dilution of 1:1000 in milk buffer.
Secondary antibody was added at a dilution of 1:10,000 in milk buffer. Following each
antibody incubation, the membrane was triple rinsed with TBST. Chemiluminescent
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visualization of blots was carried out using visualization solution made up of two buffers
(buffer 1: 2.5 mM luminol, 0.396 mM coumaric acid, and 100 mM Tris-HCl pH 8.5; buffer 2:
0.0192% hydrogen peroxide, 100 mM Tris-HCl pH 8.5) mixed immediately before
visualization.

The following primary antibodies were used: GAPDH loading control antibody MA5-15738
(Thermo Fisher Scientific), anti-RIOK3 SAB1406721 (Sigma), and anti-TRA2-b antibody
ab31353 (Abcam). HRP-conjugated secondary antibodies used were anti-Mouse IgG
peroxidase antibody produced in goat A2554 (Sigma) and anti-Rabbit IgG peroxidase
antibody produced in goat A0545 (Sigma).

Transfection
Plasmid transfections were performed on HEK293 cells using Lipofectamine 2000 as per the
manufacturer’s instructions (Thermo Fisher Scientific, Waltham, USA). Morpholino oligos
were synthesized by Gene Tools and transfected using Endo-Porter according to the
manufacturer’s instructions (Gene Tools).

Results
RIOK3 is alternatively spliced during infection and in multiple cell types
In cell culture, RIOK3 mRNA is expressed as four major splice isoforms termed full-length
(FL), X2, X1, and X1/X2 hybrid whose abundances depend on cell treatment and/or cell type
(Figure 13A). FL represents the constitutively spliced mRNA that is abundant in nonimmune-activated cells and contains the entire coding sequence for the full length RIOK3
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protein. The X2 isoform is produced due to an alternative 5’ splicing event in exon 8, which
leads to a PTC in exon 9. X1, the least abundant isoform that is not readily identified via
agarose gel, contains a skipped exon 7. Additionally, we observe a hybrid X1/X2 splicing
event where both exon 7 is omitted and the alternative splice site in exon 8 is observed.

RIOK3 was alternatively spliced in HEK293 cells during the course of RVFV strain MP-12
infection. As early as 18 hours post infection, abundance shifts from primarily FL to X2, with
some increase in X1/X2 hybrid (Figure 13B). RIOK3 protein, visualized via western blot
(Supplementary Figure 13), is either unaffected or slightly increased by RVFV infection,
which is not unexpected because we previously demonstrated that both alternative splicing
of RIOK3 mRNA and RIOK3 protein abundance have roles in downregulating RIOK3’s activity
on innate immunity (Havranek et al., 2021). The RIOK3 constitutive-to-alternative splicing
pattern was also consistently observed during RVFV infection of multiple cell lines, including
HEK293 (human embryonic kidney), HeLa (human cervical carcinoma), SH-SY5Y (human
neuroblastoma), HepG2 and HC-04 (human hepatoma), HFF (transformed human foreskin
fibroblasts), and Vero (African green monkey kidney) (Figure 13D).
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Figure 13: RIOK3 mRNA is alternatively spliced during RVFV infection in multiple cell types. (A)
Schematic illustration of RIOK3 splice sites observed. Single lines are introns, while boxes are
exons. (B) RT-PCR visualized by agarose gel showing alternative splicing of RIOK3 pre-mRNA
after infection with RVFV MP-12 at MOI 1. (hpi: hours post infection.) (C) RT-PCR showing
RIOK3 alternative splicing in multiple cell lines in response to RVFV MP-12 infection. HEK293
(human embryonic kidney), Hela (human cervical carcinoma), HEPG2 (human hepatoma), HC04 (human hepatoma), Vero (African green monkey kidney), SH-SY5Y (human neuroblastoma),
and HFF (human foreskin fibroblast) were used.
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Alternative splicing of RIOK3 occurs after IFNB activation
We previously showed that altering the balance of FL to alternatively spliced RIOK3 mRNA
causes ineffective activation of innate immune responses (Havranek et al., 2021). Because
overstimulation of innate immunity can lead to cell death and tissue damage (reviewed in
Rock and Kono, 2008), and can lead to autoimmune disease (Rodero and Crow, 2016), we
hypothesized that RIOK3 splicing may modulate the immune/inflammatory response after
an initial robust reaction to pathogen incursion. In particular, if proteins synthesized from
the different mRNA isoforms performed distinct functions, the relative abundances of FL, X2
and X1 could provide a mechanism for rapid tuning of the innate immune response and could
prevent unwarranted collateral cell damage and apoptosis.
RIOK3 protein has a role downstream of RIG-I stimulation, which culminates in homo- and
heterodimerization of IRF3/IRF7 and activation of interferon-stimulated genes including the
cytokine interferon beta (IFNB) (Ning et al., 2011; Tsoi et al., 2019). Therefore, we measured
IFNB production as a proxy for innate immune activation. Cells were infected with RVFV and
harvested as the innate immune response was being activated. We measured IFNB
production via RT-qPCR, and simultaneously assayed RIOK3 splicing patterns by visualizing
RT-PCR products by agarose gel electrophoresis. We found that RIOK3 alternative splicing
isoforms were not abundant in the first 7 hours of infection, but significant IFNB expression
was detected beginning at 6 hpi (Figure 14A-B). These data indicated that innate immune
activation preceded RIOK3 alternative splicing.
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To determine whether IFNB itself could trigger RIOK3 alternative splicing, we also treated
cells with IFNB protein. While IFNB is readily expressed after innate immune activation via
RIG-I activation (Kato et al., 2006), the protein is secreted and subsequently interacts with
interferon receptor complexes, initiating JAK/STAT signaling (Velazquez et al., 1992; Müller
et al., 1993) and activating a separate set of genes from those expressed as a result of RIG-I
activation (Qureshi et al., 1996; Mesev et al., 2019). We observed no increase in alternative
splicing of RIOK3 when cells were treated with IFNB protein, indicating that the splicing
event is likely unique to the initial activation of innate immunity and IFNB induction via RIGI and not via paracrine or endocrine signaling by IFNB protein (Figure 14C).
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Figure 14: RIOK3 splicing occurs after IFNB activation, and is not affected by IFNB protein. (A)
RIOK3 alternative splicing over the first 7 hours of RVFV MP-12 infection in HEK293 cells at
MOI 1, as measured by RT-PCR. (B) IFNB expression measured by qPCR at each timepoint
corresponding to RIOK3 alternative splicing in response to RVFV MP-12 infection in the same
HEK293 cells as in (A). Asterisks indicate p < 0.05 compared to mock-infected cells (one-way
ANOVA followed by Tukey’s HSD). (C) HEK293 cells in a 24-well plate were treated with 0,
0.125, 0.25, or 0.5 µg/ml of IFNB protein for 24h, and RNA was extracted. RT-PCR was
performed to amplify RIOK3 mRNA.
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RIOK3 transcript isoform abundance is regulated by splicing factor TRA2-b
Serine-arginine-rich (SR) splicing factors are a family of splicing factors that control both
constitutive and alternative splicing and can promote exon skipping or inclusion.
Constitutively spliced isoforms are those that are most abundant at a cell’s basal level. All SR
splicing factors have an RNA-recognition domain and a serine-arginine-rich region that
interacts with spliceosomal proteins. SR splicing factors have several roles in splicing, but
generally work by binding RNA and recruiting spliceosomal proteins, thereby enhancing the
usage of specific splice sites (Zahler et al., 1992; Zhang and Wu, 1996). TRA2-b is an SR
splicing factor that usually acts as an exonic splicing enhancer by binding to clustered
(A)GAA motifs in pre-mRNA (Tacke et al., 1998; Glatz et al., 2006; Best et al., 2014).

We used SFmap, a web-based splicing factor motif prediction tool, to query the RIOK3 exon
8 mRNA sequence for putative splicing factors (Akerman et al., 2009; Paz et al., 2010). The
SFmap algorithm uses two characteristics of splicing motifs to predict splice sites: 1) the
propensity for splicing factor motifs to be in repeated clusters (Ule et al., 2006) and 2) the
tendency for splice site motifs to be evolutionarily conserved (Goren et al., 2006). According
to the SFmap results, RIOK3 pre-mRNA has two potential TRA2-b binding clusters. To assess
whether these TRA2-b binding motifs were active in RIOK3, we first overexpressed TRA2-b
in HEK293 cells and performed RT-PCR on endogenous RIOK3 mRNA. TRA2-b
overexpression paralleled an increased abundance of RIOK3 FL in mock and infected cells,
indicating that exon 8 has at least one binding site that is responsive to TRA2-b protein levels
(Figure 15A).
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Figure 15: RIOK3 mRNA alternative splicing bias is controlled by TRA2-b. (A) HEK293 cells
were transfected with TRA2-b overexpression plasmid or GFP control for 24h, then infected
with RVFV MP-12 (MOI 1) or mock for 24h before harvesting. RT-PCR shows RIOK3 splice
isoforms. (B) HEK293 cells were transfected with TRA2-b overexpression plasmid. 24h posttransfection, cells were lysed and a western blot was performed to estimate overexpression. (C)
HEK293 cells were treated with TRA2-b poison exon-inducing morpholino oligonucleotides
(MO) at 10 μM for 24h, and RT-PCR was performed using TRA2-b primers. (D) HEK293 cells
were treated with 5 μM MO for 24h, and lysate was used for a western blot to estimate
knockdown of TRA2-b. (E) HEK293 cells were treated with MO as in panel C, and RT-PCR was
performed using primers against RIOK3. (F) HEK293 cells were treated with MO as in panel C
and RNA was used to perform RT-qPCR. RIOK3 exons 1-2 were used to measure overall
expression of the mRNA. Each lane indicates data from biological triplicates and technical
duplicates. Asterisk indicates p < 0.05 compared to mock transfection (Student’s t-test). (G)
Schematic illustration of RIOK3 splicing minigene. RIOK3 exons 8 and 9 were cloned into
pSpliceExpress vector, and primers spanning the splice junction between the rat insulin exon
and the RIOK3 exon were used to amplify cDNA for RT-PCR. Lower panel shows mutations in
putative TRA2-b binding sites. (E) RT-PCR using splice junction-spanning primers to amplify
minigene cDNA.

Next, we wanted to assess whether knockdown of TRA2-b had the opposite effect as
overexpression. However, siRNA is a known activator of innate immunity by activation of
the RIG-I pathway (Meng and Lu, 2017; Takahashi et al., 2018). Furthermore, RIOK3 has
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been shown to be alternatively spliced due to RIG-I activation alone (Havranek et al., 2021).
Therefore, we could not use siRNAs to decouple RIG-I-caused RIOK3 splicing from siRNAcaused RIOK3 splicing. Instead, we administered a morpholino oligo (MO; GeneTools LLC)
designed to obscure an hnRNPA1 binding site on TRA2-b pre-mRNA. Binding of hnRNPA1, a
splicing silencer, normally silences inclusion of a poison exon and results in normal
expression of TRA2-b (Leclair et al., 2020). Occlusion of the binding site results in inclusion
of the poison exon and rapid degradation of the mRNA by nonsense-mediated decay (Stoilov
et al., 2004b; Leclair et al., 2020). MOs are highly stable oligonucleotide mimics that are not
degraded by cellular machinery, do not elicit antiviral responses, and can be used to occlude
splice sites or protein-binding motifs (Summerton, 2007; Regis et al., 2013). Upon treating
cells with the TRA2-b knockdown MO, we observed a modest increase in TRA2-b poison exon
expression (Figure 15C), a decrease in TRA2-b protein (Figure 15D), and a resulting increase
in RIOK3 X2 (Figure 15E). We confirmed the latter results through RT-qPCR targeting RIOK3;
while RIOK3 overall expression (measured by non-alternatively spliced exons 1-2) did not
change, we see a small but insignificant change in FL and a statistically significant 2-fold
increase in X2 after treating with MO (Figure 15F).

We next constructed RIOK3 splicing minigenes to assess the importance of the putative
TRA2-b binding sites (highlighted in Figure 15G) that could impact RIOK3 splicing. The
minigene was constructed using pSpliceExpress, a previously described backbone, which
contains rat insulin exons (Kishore et al., 2008), between which we inserted RIOK3 exons 8
and 9, intron 8, and 448 bp (upstream) and 250 bp (downstream) of the surrounding intronic
region. We used primers that overlapped the rat insulin exons and RIOK3 exons to isolate
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for spliced mRNA derived solely from the minigene. We constructed a wildtype-like
minigene, two mutant minigenes with nucleotides in the putative TRA2-b binding clusters
C1 or C2 mutated, and a fourth minigene mutated in both C1 and C2 (Figure 15G). An increase
in FL RIOK3 was observed when we transfected cells with theTRA2-b expression construct,
and mutation of putative TRA2-b sites caused complete (C1) to partial (C2) loss of FL RIOK3
mRNA (Figure 15H). We also observed FL’, an isoform derived from a cryptic splice site only
observed in the minigene, indicating that some of the normal splice-specific context may be
missing from the minigene. A weak 5’ splice site downstream of the FL splice site can be
predicted via splice prediction software NetGene2 (Brunak et al., 1991; Hebsgaard et al.,
1996), so we expect that a strong splicing factor binding site outside the region cloned into
the minigene is responsible for avoiding FL’ in normal cells. These data demonstrate that
splicing patterns of the RIOK3 minigenes are exquisitely sensitive to the presence of TRA2b as well as the TRA2-b recognition sequences found in the cellular RIOK3 pre-mRNA.

Lastly, we wanted to ask whether TRA2-b protein was present at the splice site. We
investigated previously published iCLIP data by Best, et al. (GEO dataset GSE59335) where
the authors sequenced and analyzed RNA bound to TRA2-b protein (Best et al., 2014). Using
Integrated Genomics Viewer (Robinson et al., 2011) to visualize alignments from our
previously published RNAseq dataset (Havranek et al., 2019), we found TRA2-b clusters in
RIOK3 exon 8 in the iCLIP data, supporting our hypothesis that RIOK3 constitutive splicing
is controlled by TRA2-b (Figure 16).
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Figure 16: TRA2-b interacts with RIOK3 mRNA. (A) RNAseq-derived Integrated Genomics
Viewer (IGV) tracks of mRNA expression in mock- vs. RVFV MP-12-infected HEK293 cells
highlighting RIOK3 (data are from Havranek, et al., 2019). TRA2-b-bound iCLIP cluster reads
from Best, et al. (2014; GEO accession number GSE59335) are aligned below.

TRA2-b mRNA is alternatively spliced during a RVFV infection to a nonfunctional isoform
TRA2-b protein regulates its own expression by binding to TRA2-b pre-mRNA in an autoregulatory feedback loop (Stoilov et al., 2004b). When TRA2-b protein is (over-) abundant,
it binds to its pre-mRNA and forces the inclusion of an alternatively spliced non-coding
“poison” exon in the mature mRNA, which leads to rapid degradation of the mRNA through
nonsense-mediated decay. Dysregulation of this system can disrupt constitutive splicing in
cells; some mutations that disrupt poison exons can cause disease such as cancer (Yoshida
et al., 2011; Liang et al., 2018). Additionally, poison exons are present and ultraconserved in
all members of the SR splicing factor family (Lareau et al., 2007; Ni et al., 2007; Leclair et al.,
2020). We had previously observed that the balance of TRA2-b splicing isoforms was skewed
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toward the poison exon-containing isoform in an RNAseq study on RVFV MP-12-infected
cells (Figure 17A).

We infected HEK293 cells with RVFV MP-12 and observed TRA2-b mRNA splicing via RTPCR, and compared the splice pattern to that caused by sodium arsenite, a treatment that
was previously shown to induce TRA2-b poison exon inclusion in response to oxidative
stress (Akaike et al., 2014). In RVFV-infected cells, the TRA2-b splicing pattern was altered
to favor the longer isoform which includes the poison exon (Figure 17B). We observed a
time-dependent accumulation of the poison exon isoform upon longer infection of RVFV MP12, up to 48 hpi (Figure 17C). This was supported by our observation of a decrease in
endogenous TRA2-b protein in infected cells (Figure 17D). Next, because we previously
reported that RIOK3 overexpression was detrimental to RVFV replication (Havranek et al.,
2021), we asked whether TRA2-b overexpression, which would increase FL RIOK3 in cells,
would also reduce RVFV MP-12 infection. In support of this hypothesis, we observed a
decrease in extracellular viral particles measured by TCID50 assay (Figure 17E).
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Figure 17: TRA2-b mRNA is alternatively spliced in response to RVFV infection. (A) IGV tracks
of mock- vs. RVFV MP-12-infected HEK293 cells at MOI 1, highlighting TRA2-b. TRA2-b poison
exon is labeled. (B) HEK293 cells were treated with sodium arsenite in increasing amounts (0,
1, 10, 25, 50, or 100 µM) or infected with RVFV MP-12 for 24h. RT-PCR with primers targeting
TRA2-b mRNA was visualized by agarose gel. (C) HEK293 cells were infected with RVFV MP-12
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at MOI 1 for the times indicated, and RT-PCR against TRA2-b was performed. (D) HEK293 cells
were infected with RVFV for 24h at MOI 1, then cells were lysed and visualized via western blot.
(E) TCID50 results obtained by infecting naïve Vero cells using RVFV MP-12 particles obtained
from HEK293 cells transfected with indicated plasmids and subsequently infected with RVFV
MP-12 at MOI 1. Asterisks indicate p < 0.05 compared to GFP transfection (one-way ANOVA
followed by Tukey’s HSD).

Discussion
We previously demonstrated that RIOK3 plays an important role in the cellular response to
RVFV infection. In this study, we examined RIOK3 alternative splicing in the context of RVFV
infection and observed that splice site selection in this gene is at least partially controlled by
the exonic splicing enhancer TRA2-b. Interestingly, TRA2-b itself is also alternatively spliced
during RVFV infection, which likely affects its expression.

RIOK3 is a still incompletely understood member of the atypical protein kinase subfamily
whose functions have been variously associated with ribosome assembly, erythrocyte
maturation, cellular immunity, and the hypoxia response (LaRonde-LeBlanc and Wlodawer,
2005; Shan et al., 2009; Zhang et al., 2011; Baumas et al., 2012; Feng et al., 2014; Singleton
et al., 2015; Takashima et al., 2015). In different cellular and viral contexts, its expression
appears to be important for either activation (Feng et al., 2014; Willemsen et al., 2017;
Havranek et al., 2021) or deactivation (Takashima et al., 2015; Willemsen et al., 2017; Shen
et al., 2021) of the cellular immune response. RIOK3 mRNA was found to be alternatively
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spliced during RVFV infection (Havranek et al., 2019; Havranek et al., 2021), and in this work
we demonstrated that this alternative splicing event is observed in both human and monkey
cell types, suggesting that alternative splicing at this site is evolutionarily conserved. We
previously demonstrated that constitutive RIOK3 splicing is required for productive
expression of IFNB, and we hypothesize that RIOK3 alternative splicing may be a mechanism
to regulate the innate immune response. We also showed that RIOK3 alternative splicing is
only activated by primary innate immune activation and not activated by downstream
cytokine (IFNB) signaling that may occur via autocrine or paracrine activation of interferon
receptors. These data, in conjunction with our previously reported data using RIG-I and
MDA5 agonists (Havranek et al., 2021), indicate that the alternative splicing event is
triggered in the early stages of the activation of the antiviral state via RIG-I or MDA5.

Regulation of cellular immunity at the splicing level by expression of an alternative splice
isoform, either nonfunctional or inhibitory towards its normal binding partners, is an
established mechanism for other innate immune proteins, possibly to prevent
overstimulation of the innate immune response and cell death. For example, a short isoform
of RIG-I missing its CARD domain, required for TRIM25 binding, K-63 ubiquitination and
activation of RIG-I signaling, is expressed within 24h after Sendai virus infection (Gack et al.,
2008). Likewise, a truncated version of TBK-1 that binds to RIG-I, but not the downstream
interactor MAVS (also known as VISA), is expressed as early as 6h after infection of Sendai
virus, effectively disrupting the innate immune response (Deng et al., 2008). In MAVS,
another protein downstream of RIG-I, alternative splice isoforms (apparently expressed
constitutively) are unable to interact with TRAF proteins required for IFNB expression (Lad
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et al., 2008). In OAS1g, a potent innate immune activator, an alternative splice site leading to
transcripts degraded by nonsense mediated decay is preferred to prevent excess apoptosis
(Frankiw et al., 2020). An altogether different mechanism exists for IRF3, where instead of
expressing an alternative isoform, an SR splicing factor (SRSF1) is responsible for
constitutive splicing of mRNA during innate immune activation (Guo et al., 2013). In this
context, RIOK3 joins a rich family of proteins associated with the antiviral state that are
regulated via splicing.

Here, we demonstrated that splicing of RIOK3 pre-mRNA is at least partially controlled by
TRA2-b, which implicates this splicing factor as a regulator of one facet of the innate immune
response. TRA2-b is one of 12 members of the SR splicing factor family that form a tightly
co-regulated web to correctly splice mRNA (Long and Caceres, 2008; Leclair et al., 2020).
Each SR splicing factor has at least one poison exon, which is in turn regulated by other SR
spicing factors. It is likely that SR splicing factors are required for the alternative splicing
that occurs during viral infection, but the exact roles of each SR protein during infection
remain unclear. To our knowledge, TRA2-b has not been implicated in regulation of the
immune response, but has been reported to be a constitutive splicing factor involved in the
splicing of a diversity of mRNAs during normal cellular function and development (Hofmann
et al., 2000; Grellscheid et al., 2011; Elliott et al., 2012). As an upstream factor of innate
immune activation, altering TRA2-b concentration could be an early switch for alternative
splicing in response to infection.
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We cannot rule out that other splicing factors might also contribute to constitutive or
alternative RIOK3 pre-mRNA splicing. However, since the principal mRNA isoforms detected
in all tissue types are of the FL, X1, and X2 types surrounding exons 7, 8 and 9, and regulation
of this splicing is strongly impacted by levels and binding of TRA2-b, it appears that this
splicing factor is the primary regulator of RIOK3 splicing. Additionally, according to our RNA
seq data (Havranek et al., 2019), only two other SR splicing factors are alternatively spliced
in response to RVFV MP-12 infection: TRA2-a, and SRSF11. TRA2-a is a partial paralogue to
TRA2-b (Dauwalder et al., 1996), and also has an increased poison exon inclusion, and
therefore likely less protein. SRSF11 encodes the protein p54 that binds to intronic C-rich
regions (Kennedy et al., 1998). RIOK3 pre-mRNA does not contain intronic C-rich stretches.
It is intriguing that the pre-mRNA for TRA2-b is also alternatively spliced to include a poison
exon as a result of RVFV infection. As inclusion of the poison exon decreases expression of
the TRA2-b protein, it is plausible that the decrease in TRA2-b concentration results in
alternative splicing of RIOK3 and other mRNAs. The signal(s) that trigger alternative splicing
of TRA2-b pre-mRNA during viral infection will be an intriguing avenue of investigation. One
intriguing possibility is through the TRAF6-mediated K-63 ubiquitination and nuclear
localization of hnRNPA1 during innate immune activation (Culver-Cochran and
Starczynowski, 2018); if the activity of TRAF6 is inhibited during infection, hnRNPA1 activity
could drop, leaving TRA2-b pre-mRNA vulnerable to inclusion of the poison exon. TRAF6 is
known to be targeted for degradation during flavivirus infection (Chan et al., 2016; Dainichi
et al., 2019). Although it is possible that a general reduction in transcription by viral protein
NSs could be responsible for the decreased expression of RIOK and TRA2-b mRNA(Billecocq
et al., 2004), we noted an increase in mRNA in these transcripts in our RNAseq data
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(Havranek et al., 2019), indicating that RIOK3 and TRA2-b are not affected by NSs
transcriptional shutdown.

It will be of interest to examine how RIOK3 alternative splicing causes a reduction in virusinduced IFNB production, either through the expression of a truncated protein encoded by
the X2 isoform, or through reduction of the intracellular levels of constitutively spliced
mRNA, or both. Additionally, the apparently conflicting results of RIOK3’s reported activity
in different cell types and during infection with different viruses suggests that RIOK3’s role
depends on the antiviral pathways that are activated and inhibited during infection, which
may also depend on the isoforms of RIOK3 that are expressed in response to infections with
different viruses. Finally, TRA2-b’s ability to regulate alternative splicing and the fact that it
is the prone to alternative splicing itself emphasize its potential to act as a central regulator
during the cellular antiviral immune response. We anticipate that documentation of TRA2b’s
roles during these dynamic events in the cell will continue to expand.

Supplementary Figure 1
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Supplementary Figure 1: RIOK3 expression at various timepoints following RVFV infection.
HEK293 cells were infected with RVFV at MOI 1 for the times indicated, then cells were lysed
and visualized by western blot.
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Chapter 5: Discussion
Overview
Cellular innate immunity is a vital mechanism to protect cells from viral infection, and RIOK3
is an emerging important member of this key cellular pathway. To better understand human
disease caused by viruses, it is important to study the complex signaling cascades that
control innate immunity. While many of the main players involved in innate immune
activation are fairly well understood, the roles of many vital but peripheral proteins involved
in activation and regulation are less clear. The overarching goal of this dissertation has been
to understand the role of RIOK3 in RVFV-infected cells, and the occasionally contradictory
roles it may play in innate immunity, through molecular and transcriptomics approaches.

RVFV infection leads to extensive changes in the cellular transcriptional landscape,
especially in mRNAs that are alternatively spliced, as described in Chapter 2. An intriguing
member of the innate immune response whose mRNA becomes alternatively spliced during
RVFV infection is RIOK3, an atypical protein kinase of unclear function: reports have differed
for RIOK3’s function during infection, with some authors arguing that it aids in innate
immune activation (Feng et al., 2014), while others asserting the opposite (Takashima et al.,
2015; Shen et al., 2021). In Chapter 3, we reported that RIOK3 is an essential member of
innate immune signaling during RVFV infection, and, importantly, we show that alternative
splicing of RIOK3 activated shortly after infection is detrimental to interferon beta (IFNB)
expression. In Chapter 4, further investigation of the RIOK3 splice event indicated that
constitutive RIOK3 splicing is under the control of host splicing factor TRA2-b, and that
depletion of TRA2-b during RVFV infection is likely causing the alternative splicing of RIOK3.
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Interestingly, TRA2-b overexpression also caused a decrease in RVFV infection, suggesting
that the increased expression of full length RIOK3 might be enough to reduce RVFV
replication.

In this chapter, we will describe the overall importance of understanding RIOK3’s role in an
infected cell, compare our results to those of others in the field to propose roles for RIOK3
that best fit the available data, and discuss potential future directions for understanding
RIOK3’s precise interactions during innate immune activation.

RIOK3’s reportedly opposing functions
RIOK3 appears to have a key role in innate immunity, but depending on the publication, it
appears to have two contradictory functions. According to Feng et al., RIOK3 acts as a
necessary innate immune activator that works as an adaptor between TBK1 and IRF3 (Feng
et al., 2014). Our research corroborates this interpretation: in Chapter 3, we demonstrate
that RIOK3 knockout cells have severely impaired innate immune activation as measured by
IFNB mRNA. On the other hand, a few other reports argue the opposite is true: that RIOK3
has a negative effect on innate immunity and that it is used to shut down innate immune
activation. Takashima et al., found that RIOK3 was responsible for phosphorylation and
subsequent deactivation of MDA5 (Takashima et al., 2015). Shen and colleagues arrived at a
similar conclusion, reporting that RIOK3 interacts with ubiquitin ligase TRIM40 and guides
it to RIG-I and MDA5 for K-48-linked ubiquitination and proteasomal degradation (Shen et
al., 2021). Shan, et al., also found a negative regulatory role for RIOK3 in the NF-kB pathway,
where it apparently represses caspase-10 (Shan et al., 2009). The NF-kB results may be
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worth investigating more, as NF-kB causes upregulation of TNFa, a completely separate
pathway from IFN. RIOK3 could be a core regulator for differentiating between the IFN and
TNFa activation pathways.
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Figure 18: A schematic diagram of RIOK3’s apparently opposing roles in innate immune
regulation, with sources for each of RIOK3’s reported roles.
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What might account for the conflicting results between laboratories? There were a few
differences between the experiments of Shen, et al., and those of the Lodmell lab and Feng,
et al. Foremost is the use of different cell types: we used HEK293 cells, which are human
embryonic kidney cells (i.e., they are cells not specifically involved in immune response
mobilization, whereas Shen used primary mouse macrophages (i.e., cells that specifically
induce the immune response) for the bulk of their experiments. There may be core
differences in RIG-I and MDA5 signaling in these two cell types because of their distinct roles
in the body: specifically, macrophages are immune cells, while HEK293 cells are not, and
therefore the two may have distinct purposes for RIOK3. Species differences could also
potentially play a role in the discrepancies between our data and Shen’s, as Shen used mouse
primary macrophages compared to our human cell line. Shen pins RIOK3’s role of lowering
innate immune activation to the E3 ubiquitin ligase TRIM40. Interestingly, TRIM40 reads in
our RNAseq data (from Chapter 2) are near zero (compared to the thousands of reads
elsewhere), which may account for at least some of the difference in RIOK3’s role in our two
systems. Future experiments could include TRIM40 overexpression in HEK293s, as well as
comparing the effect on IFNB expression caused by RIOK3 overexpression/knockdown in a
variety of cell types. If TRIM40 were expressed in HEK293 cells, we might expect decreased
expression of IFNB during RIOK3 expression, similar to Shen’s results. In different cell types,
if TRIM40 is important, increased RIOK3 will cause lower expression of IFNB in cells with
high TRIM40, and higher expression of IFNB in low-TRIM40 conditions. If TRIM40 is indeed
the defining factor, understanding TRIM40’s expression profile in different cell types could
be important to understanding their response to innate immunity. Experiments to
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investigate the effects of exogenous expression of TRIM40 in HEK293 cells are underway in
our group.

RIOK3 has been shown to interact with a diverse group of proteins other than TRIM40,
including innate immune members TBK1, MDA5, and IRF3 (Feng et al., 2014; Takashima et
al., 2015), alongside some interactions outside innate immunity such as ribosome subunits
and actin (Baumas et al., 2012; Singleton et al., 2015). RIOK3 also binds ubiquitin, which may
link it to TRIM40. In an unbiased survey of proteins that bind to different types of ubiquitin
chains, it was found that RIOK3 interacted preferentially with K63-polyubiquitin, which is a
hallmark post translational modification seen in immune activated cells (Kong et al., 2019).
Through these diverse interactions, RIOK3 may function in capacities we haven’t yet
determined or even imagined as of yet. Though not explored in detail in this dissertation, we
have carried out a biotin proximity ligation and mass spectrometry assay in collaboration
with Drs. Ben Major and Dhaval Bhatt at Washington University in St. Louis, and a yeast twohybrid assay with Dr. Joel Graff at Montana Technological University in Butte, MT to identify
RIOK3’s unreported binding partners.

RIOK3 can also be a positive or negative regulator of viral infection, depending on the virus
studied. For RVFV (bunyavirus) and hepatitis C virus (flavivirus), RIOK3 inhibits viral
replication (Gokhale et al., 2020; Havranek et al., 2021). On the other hand, in Zika virus,
Dengue virus (both flaviviruses), measles virus, vesicular stomatitis virus (rhabdoviruses),
and Sendai virus (paramyxovirus), RIOK3 appears necessary for robust replication
(Takashima et al., 2015; Gokhale et al., 2020; Shen et al., 2021). For influenza A virus
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(orthomyxovirus), RIOK3 has been shown to be inhibitory by Feng, et al., and required by
Shen, et al. Interestingly, RIOK3 has no effect on DNA viruses (Shen et al., 2021), and DNA
viruses do not seem to have any difference in IFNB production whether RIOK3 is absent or
present (Havranek et al., 2021), indicating that RIOK3 is only required in the RNA-sensing
pathway of viral recognition. However, it is still unclear why RIOK3 has a different role in
different RNA virus systems, and careful consideration of the role it plays in different viral
infections will be important to study in the future. Regardless, it seems likely that some
viruses may target RIOK3 to avoid detection by the host cell.

Although the function of full-length RIOK3 protein is not completely understood, our work
has clarified the importance of the alternatively spliced isoforms (highlighted in Figure 19).
None of the other publications focusing on RIOK3 have studied either of the major splice
variants, which we termed X1 or X2, in the context of innate immune activation. Using
morpholino oligonucleotides, we observed that biasing the splicing pattern toward X2
expression resulted in lower interferon expression after innate immune activation (Chapter
3, (Havranek et al., 2021)). We hypothesize that this splicing shift may work similarly to the
patterns observed in other innate immune proteins (discussed in Chapter 1). We
hypothesize that RIOK3 X2 protein reduces innate immune activation as a dominant negative
inhibitor. It would be interesting to express RIOK3 X2 protein in different cell lines to
observe whether, like RIOK3 FL, it binds TRIM40 and ubiquitin. X2 protein is missing a large
portion of the RIO domain, the catalytic domain conserved between RIOK1, RIOK2, and
RIOK3. The X2 mRNA isoform encodes a premature stop codon 26 residues after the
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putatively catalytic kinase residue K290. If the RIO domain is important for RIOK3’s activity,
X2 would likely be deficient for that activity.
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126

Splicing factors in innate immunity
In Chapter 4, we showed that RIOK3 full-length mRNA is spliced by splicing factor TRA2-b.
Splicing factors form complex networks, often by directly influencing the expression of other
splicing factors. For example, Leclair et al., published an impressive RNAseq study in which
they measured alternative splicing of serine-arginine (SR) splicing factors. SR splicing factors
typically bind exons and promote their inclusion in mature mRNA. Leclair found that SR
splicing factors in different tissue types had different expression profiles, and that
knockdown of particular SR splicing factors caused massive changes to the splicing of other
SR splicing factors (Leclair et al., 2020). Their results painted a richly complex picture of
splicing factor interactions, whereby each individual splicing factor affected the splicing of
other splicing factors, with variable results depending on tissue type. While Leclair et al.,
reported changes in splicing factor abundance in cancer cells, our work implicates the SR
splicing factors as potential regulators of innate immunity. SRSF1 has previously been shown
to be responsible for splicing of IRF3 and other innate immune members (Solis et al., 2006;
Paz et al., 2021), but other SR splicing factors’ roles in innate immunity have not been
determined. TRA2-b may be responsible for regulating splicing patterns of other innate
immune members, or it may be instrumental in the expression of other SR splicing factors.

If infection by a virus, such as RVFV, interferes with splicing or abundance of TRA2-b, it may
also cause mis-splicing elsewhere in the genome. There is corroborating evidence of this
mechanism for increasing viral replication, as reovirus can inhibit SRSF2 to affect splicing
and reduce interferon expression (Rivera-Serrano et al., 2017). Whether it is common for
viruses is unclear, but it is could be valuable to study more. In RVFV infection, it is plausible
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that one of the viral proteins interferes with TRA2-b or another splicing factor through
interactions with viral proteins. We have previously shown that RVFV N protein, an RNAbinding protein, enters the nucleus and binds host transcripts (Hayashi et al., 2021), a
mechanism that could interfere with host splicing. Additionally, RVFV virulence factor NSs
enters the nucleus and forms filamentous structures (Kohl et al., 1999; Li et al., 2019), which
we could hypothesize interfere with normal nuclear activity such as splicing. Regardless of
the mechanism, viral interference with splicing is an emerging field of study which may
prove important to virulence of particular viruses.

While we showed that TRA2-b is alternatively spliced during RVFV infection, the question
remains: what causes TRA2-b alternative splicing? Is it an effect of the virus, the host cell, or
both? It is possible that one or more members of the SR splicing factor family is in control of
TRA2-b splicing during innate immunity. As a preliminary investigation, we investigated our
RNAseq data for RVFV-infected cells (Havranek et al., 2019), looking for alternatively spliced
SR splicing factors with the reasoning that alternatively spliced SR splicing factors might
have different abundances in cells. We found only two additional SR splicing factors to be
alternatively spliced to include the poison exon in RVFV-infected cells: TRA2-a and SRSF11
(Figure 20). TRA2-a is a homologue to TRA2-b that targets many of the same mRNAs as
TRA2-b (Best et al., 2014), and, like TRA2-b, the poison exon was also enriched in RVFVinfected cells, so the protein expression was likely lower. SRSF11 protein, on the other hand,
may be involved because overexpression of SRSF11 induces less poison exon inclusion of
TRA2-b (Leclair et al., 2020). Loss of SRSF11 in RVFV-infected cells could cause the increase
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in TRA2-b poison exon we observe, and it could be an interesting protein to study in the
context of viral infection.

Figure 20: STRING.db network showing interactions (both protein-protein interactions and
functional interactions) between the three SR splicing factors alternatively spliced during RVFV
infection (Szklarczyk et al., 2019). The three SR splicing factors alternatively spliced (TRA2-b,
TRA2-a, and SRSF11) are highlighted in blue, SR splicing factor family members (usually exonic
splicing enhancers) are highlighted in yellow, and hnRNP splicing factors (usually intronic
splicing silencers) are highlighted in red. Darker network edges indicate stronger support for
interactions.
In the course of our studies of TRA2-b’s alternative splicing during RVFV infection, we
discovered a somewhat unexpected connection to the DNA damage response (DDR). RVFV
induces activation of the DDR (without actually causing DNA damage) (Baer et al., 2012), and
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during DDR activation, TRA2-b is alternatively spliced by RNA-binding protein and splicing
factor Hu antigen R (HuR) (Akaike et al., 2014). HuR also regulates IFN signaling, which could
give it a role in connecting the DDR to innate immune activation (Sueyoshi et al., 2018). We
hypothesize that the RVFV-induced DDR activation causes phosphorylation of HuR and
subsequent translocation to the nucleus, where it causes poison exon inclusion in TRA2-b.
We began experiments to investigate the splicing status of TRA2-b and RIOK3 in response to
DNA-damaging agents and found similar splicing patterns to those in RVFV-infected cells
(data not shown), supporting this hypothesis. Future experiments linking the DDR,
especially to investigate the phosphorylation status of HuR during RVFV infection, may be
key to untangling TRA2-b alternative splicing during infection.
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Conclusions
This dissertation describes the importance of host protein RIOK3 in limiting replication of
Rift Valley fever virus. Because of the disparate published results on RIOK3’s roles in immune
activation or suppression, it is a somewhat enigmatic member of the innate immune
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pathway. We showed data arguing that it is vital for activation of innate immunity. We also
showed that alternative splicing of RIOK3 mRNA is important for regulation of its activity,
placing it in a rich family of innate immune members which are regulated by splicing. We
demonstrated that the balance of RIOK3 mRNA splicing is controlled by splicing factor TRA2b, which implicates the ubiquitous SR splicing factors as important innate immune
regulators. We brought this work full circle by showing that TRA2-b itself aids the cell in
defense against RVFV infection by enhancing expression of the full-length splicing isoform
of RIOK3 mRNA.

Though the work in this dissertation will be key to understanding RIOK3’s function in cells,
it remains a very interesting protein with potentially dual roles in individual cells, and/or
possessing opposing roles in different cell types. These apparently contradictory roles will
be important to study further with the context gained from this dissertation. Additionally,
this work’s progress in understanding the truncated splice variant during innate immune
activation should be studied further to understand what role it appears to play in regulating
RIOK3’s normal roles in cells. It will also be important to further study the splicing factor(s)
responsible for constitutive or alternative splicing of other key innate immune members, and
whether TRA2-b controls other splice events that are as important to cellular immunity as
RIOK3.
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